glucose, (beta-d)-isomer has been researched along with Alloxan Diabetes in 259 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (1.16) | 18.7374 |
1990's | 6 (2.32) | 18.2507 |
2000's | 23 (8.88) | 29.6817 |
2010's | 143 (55.21) | 24.3611 |
2020's | 84 (32.43) | 2.80 |
Authors | Studies |
---|---|
Chen, SH; Cheng, JT; Chung, HH; Ku, PM; Wang, LY; Yu, YM | 1 |
Bian, Z; Chen, X; Chen, YY; Guo, YL; Liu, DQ; Liu, Y; Zen, K; Zhang, CY | 1 |
Kannan, Y; Kinoshita, H; Moriyama, M; Nakamura, Y; Tokunaga, M | 1 |
Kobayashi, I; Sato, N; Shimizu, H; Shimomura, Y; Takahashi, M; Uehara, Y | 1 |
Martin, H; Miller, V; Shands, JW | 1 |
Muthu, K; Sundaram, R; Vasu, G | 1 |
Wang, T; Wen, X; Xie, M; Zhang, Z; Zhou, J | 1 |
Ishihara, H; Kohno, G; Koike, M; Saito, H; Takubo, M; Watanabe, K | 1 |
Han, J; He, Y; Huang, S; Kasim, V; Liu, C; Marcelina, O; Miyagishi, M; Nugrahaningrum, DA; Wang, G; Wu, S; Zou, M | 1 |
Chen, YC; Jandeleit-Dahm, K; Peter, K | 1 |
Ali, DA; Hazem, RM; Ibrahim, AZ; Moustafa, YM | 1 |
Benigni, A; Cerullo, D; Conti, S; Corna, D; Locatelli, M; Remuzzi, G; Rottoli, D; Tomasoni, S; Zanchi, C; Zoja, C | 1 |
Abdelsalam, RM; El-Safty, H; El-Sahar, AE; Ismail, A; Saad, MA | 1 |
El Medany, AMH; Ghazala, RA; Hammadi, SHM; Khalifa, HM; Zakaria Mohammed, HS | 1 |
Hanaguri, J; Kushiyama, A; Kushiyama, S; Nagaoka, T; Watanabe, M; Yamagami, S; Yokota, H | 1 |
Balogh, DB; Barczi, A; Fekete, A; Fintha, A; Hodrea, J; Molnar, A; Saeed, A; Szabo, AJ; Wagner, LJ | 1 |
Fujihara, S; Fujita, K; Haba, R; Himoto, T; Iwama, H; Masaki, T; Morishita, A; Nakahara, M; Nishiyama, A; Okano, K; Ono, M; Oura, K; Shi, T; Tadokoro, T; Takuma, K; Tani, J | 1 |
Bautista-Pérez, R; Escalante, B; Flores-Estrada, J; Franco, M; Mercado, A; Pérez-Méndez, O; Pérez-Villavicencio, R | 1 |
Asseri, SM; Ebrahim, HA; El-Agawy, MSE; El-Shafey, M; El-Sherbiny, M; Eldosoky, M; Elsherbini, DMA; Elsherbiny, NM | 1 |
Ding, L; Jiang, X; Peng, Z; Qiu, L; Xia, X; Yao, F; Zheng, W | 1 |
Gong, Y; Jiang, L; Pei, Z; Wang, A; Wu, Y; Xia, L | 1 |
Chi, PJ; Hsieh, YJ; Hsu, BG; Lee, CJ; Lu, CW | 1 |
Iwamoto, M; Kadowaki, T; Kubota, N; Kubota, T; Sakurai, Y; Shioda, S; Wada, N; Yamauchi, T | 1 |
Abdallah, DM; Ahmed, KA; El-Abhar, HS; Fleifel, AM; Soubh, AA | 1 |
Alam, MJ; Arava, S; Banerjee, SK; Bugga, P; Katare, P; Maulik, SK; Meghwani, H; Mohammed, SA | 1 |
Bin-Meferij, MM; Eissa, H; El-Baz, AM; El-Kott, AF; El-Sokkary, MMA; Elgharabawy, RM; Hassan, HM; Khalaf, EM; Khodir, AE; Nouh, NA; Saleh, S; Shata, A; Yousef, ME | 1 |
Fan, M; Jiang, R; Jin, W; Jing, C; Piao, C; Sun, L; Zhang, Q; Zhang, Y | 1 |
Bao, Y; Pei, D; Piao, M; Tian, S; Xu, D; Zhang, J | 1 |
Chen, SY; Feng, TH; Hao, DD; Miao, HX; Shang, J; Shi, J; Wan, S; Wang, SY; Zhao, Q; Zhou, CH | 1 |
Hua, Z; Li, Y; Ma, X; Yang, J; Zheng, Z; Zhu, L | 1 |
Ahmad, M; Ajaib, M; Ishtiaq, S; Kamran, SH; Razashah, SH; Shahwar, DE | 1 |
Bonner, C; Bousquet, C; Coddeville, A; Daoudi, M; Delalleau, N; Gmyr, V; Hubert, T; Kerr-Conte, J; Martineau, Y; Moerman, E; Pasquetti, G; Pattou, F; Quenon, A; Saponaro, C; Staels, B; Thévenet, J; Vantyghem, MC | 1 |
Takakura, S; Takasu, T | 3 |
Abo-Saif, AA; El-Sayed El-Daly, M; Moustafa Ahmed, Y; Shehata Messiha, BA | 1 |
Jiang, YP; Liu, N; Ma, L; Niu, JG; Sun, T; Yang, JM; Ye, RJ; Yu, JQ; Zhang, WJ; Zheng, P | 1 |
Cho, H; Park, JH; Seo, I; Shim, HM | 1 |
Gong, M; Lee, S; Li, G; Liu, T; Meng, L; Shao, Q; Tse, G; Zhang, Z; Zhao, J; Zhao, Y | 1 |
Tahara, A; Takasu, T | 4 |
Anto-Michel, N; Bode, C; Füner, L; Gissler, MC; Goldberg, IJ; Härdtner, C; Hilgendorf, I; Hoppe, N; Mullick, A; Pennig, J; Scherrer, P; Stachon, P; Willecke, F; Wolf, D; Zirlik, A | 1 |
Huang, L; Li, N; Liu, W; Miao, J; Wang, L; Yu, J | 1 |
de Boer, RA; Rienstra, M; Silljé, HHW; Westenbrink, BD; Yurista, SR | 1 |
Abd El Fattah, MA; Ahmed, MAE; Eid, NI; Gamal El Din, AA; Gamil, NM; Maklad, YA | 1 |
Abdel-Hamid, AAM; Firgany, AEL | 2 |
Fukuda, D; Ganbaatar, B; Hirata, KI; Kusunose, K; Sata, M; Shinohara, M; Soeki, T; Yagi, S; Yamada, H | 1 |
Balogh, DB; Besztercei, B; Fekete, A; Genovese, F; Hodrea, J; Hosszu, A; Koszegi, S; Lenart, L; Sparding, N; Szabo, AJ; Wagner, LJ | 1 |
Kanasaki, K; Kitada, M; Koya, D; Li, J; Liu, H; Nitta, K; Srivastava, SP; Takagaki, Y; Takagi, S | 1 |
Abdalla, O; Dessouki, A; Kilany, O; Sasaki, K; Sayed, N; Shimoda, M; Yoshida, T | 1 |
Chen, S; Jiang, B; Le, L; Lv, Q; Xiang, J; Xiao, P | 1 |
Alves-Martinez, P; Carranza-Naval, MJ; Del Marco, A; Garcia-Alloza, M; Herrera, M; Hierro-Bujalance, C; Infante-Garcia, C; Lubian-Lopez, S; Suarez, J | 1 |
Chen, JM; Lin, J; Myint, KZ; Xia, YM; Zhang, J; Zhou, ZY | 1 |
Bgatova, NP; Dashkin, MV; Khotskina, AS; Klein, T; Klimontov, VV; Konenkov, VI; Korbut, AI; Muraleva, NA; Orlov, NB; Taskaeva, IS; Zavyalov, EL | 1 |
Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Moniwa, N; Oshima, H; Sato, T; Tanaka, M; Tanno, M; Yano, T | 1 |
Adamski, J; Artati, A; Boor, P; Droste, P; Haj-Yehia, E; Kappel, B; Klinkhammer, BM; Lehrke, M; Lopaschuk, GD; Marx, N; Maxeiner, S; Moellmann, J; Schütt, K; Verma, S | 1 |
Flatt, PR; Irwin, N; Moffett, RC; Tanday, N | 1 |
Cui, G; Deng, CK; Huang, YJ; Lei, B; Miao, YH; Mu, ZH; Qian, ZY; Shen, X; Song, JL; Wang, YY; Wu, XY; Zhang, F; Zhang, WQ; Zhang, Y; Zhou, RD; Zou, YY | 1 |
Chappard, D; Gault, VA; Mabilleau, G; Mieczkowska, A; Millar, P | 1 |
Bheereddy, P; Kalvala, AK; Kumar, A; Sherkhane, B; Yerra, VG | 1 |
Cui, X; Feng, J; Gu, L; Hong, T; Lang, S; Le, Y; Liu, J; Wang, H; Wei, R; Wei, T; Yang, J; Yang, K | 1 |
Chen, ZQ; Huang, HQ; Li, XJ; Lin, ZY; Quan, SJ; Sun, XH; Xiao, HM; Xu, ZC; Yang, Y; Zhang, M | 1 |
Asensio Lopez, MDC; Bayes-Genis, A; Fernandez Del Palacio, MJ; Hernandez Vicente, A; Hernandez-Martinez, A; Lax, A; Pascual Figal, DA; Saura Guillen, E | 1 |
Ahmed Hamza, A; Ashour, ML; El-Beshbishy, HA; Singab, ANB; Wink, M; Youssef, FS | 1 |
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J | 1 |
De Caterina, R; Doria, V; Madonna, R; Minnucci, I; Pierdomenico, DS; Pucci, A | 1 |
Adachi, E; Gohda, T; Ichikawa, S; Koshida, T; Li, Z; Murakoshi, M; Suzuki, C; Suzuki, Y; Ueda, S | 1 |
Chang, WT; Chen, ZC; Cheng, JT; Fisch, S; Hong, CS; Kang, NW; Lin, YW; Shih, JY | 1 |
Chen, J; Li, C; Sun, X; Wang, X; Zhao, G; Zhao, Z | 2 |
Adolph, TE; Folie, S; Haas, S; Haubner, BJ; Hornsteiner, F; Kaser, S; Radlinger, B; Ress, C; Salvenmoser, W; Salzmann, K; Schuetz, T; Tilg, H; Weiss, B | 1 |
Chang, WT; Chen, ZC; Ho, CH; Lin, YW; Liu, PY; Shih, JY | 1 |
Abdel-Moneim, A; El-Shahawy, AA; El-Twab, SMA; Oishi, H; Shawki, HH; Yousef, AI | 1 |
Chen, LX; Fang, L; Tan, YY; Zhang, Q | 1 |
Aplin, AC; Castillo, JJ; Esser, N; Hackney, DJ; Hogan, MF; Hull, RL; Larmore, MJ; Mundinger, TO; Zraika, S | 1 |
Ahmad, A; Alanazi, FK; Aldughaim, MS; Alqahtani, A; Alqahtani, AS; Kazi, M; Noman, OM | 1 |
Abdel-Moneim, A; Abdul-Hamid, M; Galaly, SR; Mohamed, HM; Mostafa, F | 1 |
Krejpcio, Z; Król, E; Kurek, JM | 1 |
Fukuda, S; Ishii, Y; Kemmochi, Y; Kuroki, F; Miyajima, K; Nakae, D; Ohta, T; Sano, R; Sasase, T; Sugimoto, M; Yamanaka, M; Yasui, Y | 1 |
Bian, F; Chen, L; Hao, X; Lei, P; Lu, W; Ma, W; Wang, Q; Zhang, L; Zhang, Y; Zhao, Y; Zheng, T | 1 |
Chen, L; Cheng, Y; Fang, T; Han, L; Li, T; Liu, X; Meng, Z; Sun, B | 1 |
Li, S; Si, Z; Wang, D; Xue, Y; Yang, Y; Zhang, Z | 1 |
Hadova, K; Klimas, J; Kralova, E; Krenek, P; Marusakova, M | 1 |
da Rocha, CQ; da Silva, MA; de Araújo Paula, FB; Duarte, SMDS; Figueiredo, SA; Leme, KC; Rodrigues, MR; Salles, BCC; Tangerina, MMP; Vilegas, W | 1 |
Abd El-Hameed, AM; Abd El-Twab, SM; Abdel-Moneim, A; El-Shahawy, AAG; Yousef, AI | 1 |
C, SS; Iqbal, M; Us, MR; Zin, T | 1 |
Albiero, M; Amendolagine, FI; Avogaro, A; Cappellari, R; D'Anna, M; Fadini, GP; Migliozzi, L; Rosato, A; Tedesco, S; Zuccolotto, G | 1 |
Abdel-Kareem, MA; Ahmed, AS; Elsisy, RA; Mona, MM | 1 |
Domon, A; Katayama, K; Sato, T; Suzuki, H; Tazaki, H; Tochigi, Y | 1 |
Chen, Y; He, W; Jin, Y; Li, Y; Tian, L; Yao, J | 1 |
Enomoto, A; Fujishiro, M; Ishigami, M; Ito, A; Itoh, M; Ochi, K; Ogawa, Y; Ogi, T; Ono, K; Sawada, M; Shiraki, Y; Suganami, T; Tanaka, M; Watanabe, A; Yoshioka, N | 1 |
Jin, S; Li, Y; Liu, SL; Wei, X; Yang, XY; Zhao, Y | 1 |
Chen, L; Chen, Z; Feng, W; Qi, Z; Xu, Z; Yang, X | 1 |
Belosludtsev, KN; Belosludtsev, MN; Belosludtseva, NV; Dubinin, MV; Mikheeva, IB; Starinets, VS | 1 |
An, F; Jin, T; Liu, D; Liu, M; Pan, J; Suo, M; Tian, J; Wang, X; Zhang, M | 1 |
Cazorla-Bak, MP; Chin, K; Connelly, KA; Evans, RG; Gilbert, RE; Hare, GMT; Jacobs, E; Mazer, CD; Nghiem, L; Thai, K; Vinogradov, SA; Wilson, DF; Zhang, Y | 1 |
Adamski, J; Artati, A; Federici, M; Ghesquiere, B; Kappel, BA; Lehrke, M; Marx, N; Moellmann, J; Rau, M; Romeo, F; Schuett, K; Stoehr, R; Thiele, K | 1 |
Mori, K; Nakamura, S; Ogawa, Y; Okuma, H; Sekine, T; Tsuchiya, K | 1 |
AboGresha, NM; Ahmed, AAM; El-Sayed, N; El-Sayed, NM; Mahmoud, IZ; Mostafa, YM | 1 |
Fu, Q; Li, S; Ma, S; Ma, Z; Qu, R; Sun, X; Wang, H; Xu, L | 1 |
Arsenović, M; Čapo, I; Ilić, V; Milijašević, B; Stilinović, N; Vukmirović, S | 1 |
Chung, BH; Jin, J; Jin, L; Lim, SW; Luo, K; Yang, CW | 1 |
Bai, YG; Dai, ZJ; Liu, M; Ma, YG; Wang, JW; Xie, MJ | 1 |
Wu, W; Zhou, Y | 1 |
Alejandro, Z; Cesar, APJ; Ivan, JVE; Javier, AF; Jessica, GG; Mario, GL; Ruben, RR | 1 |
Chen, S; Davidson, JA; Holland, WL; Lee, Y; Li, J; McCorkle, SK; Roth, MG; Scherer, PE; Unger, RH; Wang, MY; Wang, ZV; Yu, X | 1 |
Bjourson, AJ; Flatt, PR; Gault, VA; Millar, P; Moffett, RC; O'Kane, M; Parthsarathy, V; Pathak, N; Pathak, V | 1 |
Farhat, A; Hajjar, R; Hammoudi, N; Jeong, D; Komajda, M; Lebeche, D; Mayoux, E; Singh, R | 1 |
Hosoyamada, M; Ishizawa, K; Kuribayashi-Okuma, E; Shibata, S; Toyoki, D; Uchida, S; Xu, N | 1 |
Ji, TF; Li, XX; Liu, B; Sun, YY; Xie, YZ; Xu, F | 1 |
Bouwens, L; Martens, GA; Roels, S; Song, I | 1 |
Wu, YG; Xia, LL; Zhu, QJ | 1 |
Chao, YS; Chen, CT; Hsieh, TC; Huang, CY; Huang, YC; Huang, YL; Lee, JC; Song, JS; Wang, MH; Wu, SH; Yao, CH; Yeh, TK; Yuan, MC | 1 |
Chang, B; Chen, W; Fan, R; Guo, Y; Liu, L; Pan, Y; Zhao, R | 1 |
Chen, S; Duan, H; Hou, B; Li, F; Shi, Y; Wei, J; Wu, H; Zhang, H; Zhao, L | 1 |
Dong, Y; Li, X; Sun, J; Sun, W; Xing, Y; Xiu, Z; Yu, X; Zhang, B; Zhuang, C | 1 |
Geng, X; He, J; Huang, W; Jia, Y; Lei, L; Meng, X; Su, L; Wang, L; Yang, B; Zhang, S; Zhou, H | 1 |
Al-Sharea, A; Goldberg, IJ; Hu, Y; Huggins, LA; Murphy, AJ; Nagareddy, PR | 1 |
Li, X; Wang, K; Wang, Y; Wu, Y | 1 |
Íbias, J; Nazarian, A; O'Dell, LE | 1 |
Cao, M; Li, Y; Qin, Y; Wang, T; Xu, Y; Zhai, Q; Zhao, K | 1 |
Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Nakata, K; Oshima, H; Sato, T; Tanno, M; Yano, T | 1 |
Kondo, Y; Tahara, A; Takasu, T; Tomiyama, H | 1 |
Higashijima, Y; Inagi, R; Nangaku, M; Saito, H; Suematsu, M; Sugahara, M; Sugiura, Y; Tanaka, S; Tanaka, T; Yamaguchi, J | 1 |
Gong, S; Guo, T; Li, L; Xu, S; Zhang, C | 1 |
Bujalska-Zadrożny, M; Czerwińska, ME; Gąsińska, E; Kiss, AK; Krawczyk, P; Leśniak, A; Naruszewicz, M | 1 |
Abdurrachim, D; Chan, WX; Lalic, J; Lam, CSP; Lee, PTH; Teo, XQ; Woo, CC | 1 |
Guo, X; Li, D; Li, J; Li, S; Ren, G; Wang, N; Zhang, T | 1 |
Asahara, SI; Furubayashi, A; Kanno, A; Kawamura, M; Kido, Y; Koyanagi-Kimura, M; Matsuda, T; Ogawa, W; Okada, Y; Suzuki, E; Takai, T; Tsuchiya, S | 1 |
Wang, X; Zhai, L | 1 |
Dong, H; Hao, X; Yuan, J | 1 |
Chen, B; Chen, X; Tong, L; Zhang, J; Zhang, Y | 1 |
Assaf, N; El-Yamany, MF; Ghoneim, HA; Oraby, MA; Safar, MM | 1 |
Naik, PR; Nandini, HS | 1 |
Arvapalli, R; Bandarupalli, VVK; Blough, ER; Ginjupalli, GK; Graffeo, VA; Manne, NDPK; Rice, KM | 1 |
Ariyanti, AD; Kasim, V; Marcelina, O; Nugrahaningrum, DA; Wang, G; Wu, S; Zhang, J | 1 |
Han, H; Jiang, S; Shao, Y; Tao, J; Wei, W; Yue, H; Zhang, T; Zhao, X; Zhou, G | 1 |
Bindels, RJM; de Baaij, JHF; de Galan, BE; Gault, VA; Hoenderop, JGJ; Ma, C; Millar, PJ | 1 |
Li, Q; Liao, XY; Liu, XJ; Liu, YD; Lu, D; Mu, ZH; Qi, YH; Qian, ZY; Wan, Q; Wang, Q; Wang, X; Yang, ZH; Zhang, MY; Zhu, R; Zou, YY | 1 |
Hirata, Y; Hosooka, T; Imamura, M; Kobayashi, K; Minokoshi, Y; Nomura, K; Ogawa, W; Okada, Y; Okamoto, S; Senga, Y; Takeda, S | 1 |
Cheng, FR; Cui, HX; Fang, JL; Guo, Y; Yuan, K | 1 |
Huang, Y; Li, DD; Song, YW; Wang, JS; Yin, HJ; Zhang, L; Zhang, S; Zhang, YH | 1 |
Bi, J; Cheng, X; Dai, F; Hao, L; Huang, F; Liu, Y; Wang, C; Xu, K | 1 |
Wanner, C | 1 |
Cai, Z; Huang, J; Lei, X; Liu, Z; Luo, H; Mai, Y; Yang, Z | 1 |
Lam, SH; Lee, SS; Ruan, CT; Su, MJ | 1 |
Liu, Y; Wang, X; Wang, Y; Xia, M; Zhang, Y | 1 |
Chellan, N; Fey, SJ; Ghoor, S; Joubert, E; Louw, J; Muller, CJ; Pheiffer, C; Sanderson, M | 1 |
D'Souza, LJ; Janssen, S; Parkes, DG; Polizzi, C; Tatarkiewicz, K; Villescaz, C; Wang, Y | 1 |
Qi, XM; Shen, JJ; Wang, K; Wu, XX; Wu, YG; Xu, XX; Zhang, CQ; Zhang, W | 1 |
Hayashizaki, Y; Imamura, M; Kihara, R; Kobayashi, Y; Kurosaki, E; Li, Q; Noda, A; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Yamajuku, D; Yokono, M | 1 |
Su, SQ; Wu, YG; Xu, XX; Zhang, W; Zhao, L | 1 |
Fang, H; Jiang, WL; Kan, ZC; Zhang, L; Zhang, XL | 1 |
Deng, YX; He, MY; Lv, Y; Shi, QZ; Zhang, XJ | 1 |
Beckers, J; Hrabé de Angelis, M; Huypens, P; Neschen, S; Rathkolb, B; Scheerer, M; Schultheiss, J; Seelig, A; Suhre, K; Wolf, E; Wu, M; Wurst, W | 1 |
Akahane, K; Inoue, T; Kiguchi, S; Kobayashi, M; Maruyama, K; Mori, Y; Ojima, K; Yaguchi, A; Yokoyama, A | 1 |
Chen, C; Hao, J; Huang, H; Huang, J; Huang, K; Liu, P; Wang, S | 1 |
Arakawa, K; Hikida, K; Kakimoto, T; Kimata, H; Kuriyama, C; Lee, SP; Matsushita, Y; Nakayama, K; Qi, J; Saito, A; Shiotani, M; Taniuchi, N; Ueta, K; Watanabe, Y; Xu, JZ | 1 |
Chen, C; Hao, J; Huang, H; Huang, J; Huang, K; Li, J; Liu, P | 1 |
Sherif, IO | 1 |
Hasegawa, Y; Kim-Mitsuyama, S; Koibuchi, N; Kusaka, H; Lin, B; Ma, M; Nakagawa, T; Sueta, D; Toyama, K; Uekawa, K | 1 |
Airoldi, C; Cabrita, EJ; de Almeida, RF; Dias, C; Jesus, AR; Jiménez-Barbero, J; Macedo, MP; Marcelo, F; Martins, A; Matos, AM; Nicotra, F; Rauter, AP; Ribeiro, RT; Viana, AS | 1 |
Alkaabi, JM; Hamouda, NN; Howarth, FC; Oz, M; Qureshi, MA; Sydorenko, V | 1 |
Gangadharan Komala, M; Gross, S; Huang, C; Mather, A; Mudaliar, H; Panchapakesan, U; Pegg, K; Pollock, CA; Shen, S | 1 |
Agdauletova, S; Bottari, SP; Daiber, A; Gottschlich, A; Hausding, M; Jansen, T; Kröller-Schön, S; Mader, M; Mayoux, E; Mikhed, Y; Münzel, T; Oelze, M; Schulz, E; Stamm, P; Steven, S; Welschof, P; Zinßius, E | 1 |
Huang, W; Li, Y; Li, Z; Qian, H; Wang, X; Yang, B | 1 |
Matsui, T; Nakamura, N; Nishino, Y; Ojima, A; Yamagishi, S | 1 |
Cai, H; Chen, K; Li, X; Rajotte, RV; Rayat, GR; Wu, P; Wu, Y; Xu, B; Xu, Z; Yang, B; Zhang, B | 1 |
Huang, W; Jiao, L; Li, Z; Qian, H; Qiu, Q; Wang, X; Xu, X | 1 |
Bai, X; Bian, F; Chen, X; Chi, J; Jin, S; Li, W; Wu, D; Wu, G; Xing, S; Yang, X; Zhang, Y; Zheng, T | 1 |
Abderrahim, B; Baali, F; Boudjelal, A; Henchiri, C; Ruberto, G; Sarri, M; Siracusa, L | 1 |
Beta, T; Le, K; Li, W; Moghadasian, MH; Shen, GX; Xie, X; Zhao, R | 1 |
Alkaabi, JM; Hamouda, NN; Howarth, FC; Oz, M; Qureshi, MA | 1 |
Imamura, M; Kurosaki, E; Tahara, A; Takasu, T; Yokono, M | 1 |
Kaneto, H; Matsuoka, TA; Miyatsuka, T; Shimo, N; Shimomura, I; Takahara, M; Takebe, S; Tochino, Y | 1 |
Hirano, T; Hiromura, M; Kohashi, K; Kushima, H; Mori, Y; Nagashima, M; Terasaki, M; Watanabe, T | 1 |
Bjourson, AJ; Flatt, PR; Gault, VA; Millar, PJ; Moffett, RC; O'Kane, MJ; Pathak, NM; Pathak, V | 1 |
Chen, L; Cheng, ST; Leung, PS; Li, SY; Mayoux, E | 1 |
Hayashizaki, Y; Takakura, S; Takasu, T; Toyoshi, T | 1 |
Chen, C; Hao, J; Huang, H; Huang, J; Huang, K; Liu, P; Xiong, F; Yang, Z | 1 |
Aihara, Y; Asada, K; Douhara, A; Kawaratani, H; Kitade, M; Moriya, K; Namisaki, T; Nishimura, N; Noguchi, R; Okura, Y; Takeda, K; Yoshiji, H | 1 |
Ionkova, I; Konstantinov, S; Krasteva, I; Simeonova, R; Vitcheva, V; Zdraveva, P | 1 |
Huang, B; Jiang, QS; Wu, Y; Xue, L | 1 |
Igarashi, K; Li, Y; Zang, Y | 1 |
Borg, DJ; Flemming, NB; Forbes, JM; Fotheringham, AK; Gallo, LA; Harvie, BM; Kinneally, TL; Koepsell, H; McCarthy, DA; Panchapakesan, U; Pollock, C; Vallon, V; Ward, MS; Yeh, SM; Zhuang, A | 1 |
Bouwens, L; Bugliani, M; Cnop, M; Cunha, DA; Himpe, E; Marchetti, P; Song, I | 1 |
Abas, F; Arulselvan, P; Cheah, PS; Fakurazi, S; Muhammad, AA | 1 |
Abiko, A; Atageldiyeva, K; Fujita, Y; Haneda, M; Honjo, J; Makino, Y; Mizumoto, K; Takeda, Y; Takiyama, Y; Yanagimachi, T | 1 |
Chen, BB; Chen, GT; Song, Y; Yang, M; Zhang, W; Zhang, Y | 1 |
Chen, L; Efe, O; Klein, JD; LaRocque, LM; Sands, JM; Wang, J | 1 |
Qi, X; Shao, Y; Wang, K; Wu, Y; Xia, L; Xu, X | 1 |
Ho, CT; Huang, MT; Li, S; Liu, Y; Pan, MH; Tang, W; Wu, JC | 1 |
Chen, L; Deng, W; Lei, X; Leng, W; Liang, Z; Ouyang, X; Wu, M; Wu, Q | 1 |
Åstrand, A; Baines, DL; Baker, EH; Benjamin, A; Garnett, JP; Gill, S; Groves, H; Lundqvist, AJ; Orogo-Wenn, M; Smith, DM; Taylor, JD; Tregoning, JS; Walters, D; Wingren, C | 1 |
Jin, L; Jin, LJ; Li, XY; Lu, YN; Ma, YS; Xia, YQ; Xu, YP; Xue, HY; Zhang, P | 1 |
Dong, J; Liang, C; Lin, S; Qi, X; Ren, K; Shen, J; Wu, Y; Yuan, L | 1 |
Fujimori, Y; Isaji, M; Ishikawa-Takemura, Y; Katsuno, K; Kusama, H; Nakano, S; Nakashima, I; Ojima, K | 1 |
Qi, XM; Shen, JJ; Su, J; Wu, YG; Zhang, JJ; Zhang, P | 2 |
Guo, Y; Tang, M; Wu, G; Zhou, Y | 1 |
Hu, B; Li, DQ; Wang, CF; Xue, HY | 1 |
Cheng, JJ; Hsu, CY; Juan, YC; Lin, YL; Liu, HK; Tsai, WJ; Wang, GJ; Yang, HY | 1 |
Goyal, RK; Lakshmi, S; Padh, H; Rajani, M; Sonawane, RD; Vishwakarma, SL | 1 |
Cheng, JT; Hsu, FL; Huang, WJ; Lin, MH; Niu, HS | 1 |
Cano Megías, M; González Albarrán, O; Pérez López, G | 1 |
Chang, CC; Chao, YS; Chen, CT; Chiu, CH; Chu, KF; Hsiao, WC; Hsieh, CJ; Hsieh, TC; Huang, CY; Hung, MS; Lee, JC; Liu, YW; Song, JS; Tsai, CH; Wang, MH; Wu, SH; Yao, CH; Yeh, TK; Yuan, MC | 1 |
Kumar, M; Lal Srivastava, DS; Maurya, R; Rahuja, N; Rawat, P; Srivastava, AK | 1 |
Cekic, V; Jakovljevic, V; Mikov, M; Sabo, A; Vasovic, V | 1 |
Kase, Y; Kobayashi, H; Lee, KK; Omiya, Y; Yuzurihara, M | 1 |
He, J; Hua, H; Li, CL | 1 |
Mansoury, H; Miracle, C; Rieg, T; Singh, P; Thomson, SC; Vallon, V; Whaley, J | 1 |
Afzal, M; Afzal, O; Ahmed, S; Anwar, F; Gupta, G; Kazmi, I; Nautiyal, U; Rahman, M; Saleem, S; Shaharyar, MA | 1 |
Aslan, M; Bedir, E; Ergun, F; Orhan, DD; Orhan, N; Pekcan, M | 1 |
Gong, J; Li, F; Meng, X; Peng, Y; Tang, H; Xiao, F | 1 |
Hayashizaki, Y; Imamura, M; Kihara, R; Kobayashi, Y; Kurosaki, E; Noda, A; Qun, L; Sasamata, M; Shibasaki, M; Tahara, A; Takasu, T; Tomiyama, H; Yamajuku, D; Yokono, M | 2 |
Chen, KS; Li, X; Sun, CD; Wu, YL; Xu, CJ; Zhang, B; Zhang, JK | 1 |
Kise, M; Morikawa, K; Nonaka, S; Okuhara, Y; Tsai, YY; Usuki, S; Yu, RK | 1 |
Baluchnejadmojarad, T; Balvardi, M; Nasri, S; Rabani, T; Roghani, M | 1 |
Grempler, R; Klein, T; Luippold, G; Mark, M | 1 |
Arakawa, K; Conway, B; Conway, J; Demarest, K; Du, F; Kuriyama, C; Liang, Y; Liu, Y; Martin, T; Matsushita, Y; Polidori, D; Ueta, K; Ways, K; Xu, J | 1 |
Fukazawa, M; Fukuzawa, T; Hagita, H; Honda, K; Ikeda, S; Kawabe, Y; Kawai, M; Kawai, T; Kobayashi, T; Ozawa, K; Sato, T; Suzuki, M; Takeda, M; Yata, T | 1 |
Fushimi, N; Isaji, M; Ishikawa-Takemura, Y; Itoh, F; Shibazaki, T; Tomae, M; Yamada, M | 1 |
Huang, H; Huang, J; Huang, K; Liu, P; Peng, J; Shen, X; Xie, X | 1 |
Qi, XM; Su, J; Wang, K; Wu, YG; Zhang, JJ; Zhang, P | 1 |
Li, CW; Li, ZH; Lu, LC; Luo, MH; Xie, H; Yu, CP; Zhou, W | 1 |
Fujikura, H; Fushimi, N; Isaji, M; Ishikawa-Takemura, Y; Itoh, F; Kamada, N; Kobayashi, S; Miyagi, T; Nakabayashi, T; Ohno, K; Ozawa, T; Shibazaki, T; Shimizu, K; Shiohara, H; Teranishi, H; Tomae, M; Yonekubo, S | 1 |
Elvert, R; Glombik, H; Herling, AW; Wandschneider, J; Werner, U; Wille, A | 1 |
Deng, JJ; Liu, DL; Liu, RB; Ma, ST; Niu, R | 1 |
Cui, X; Li, W; Li, X; Sun, X; Wang, J; Yang, J; Zhu, Q | 1 |
Chang, MJ; Wang, JL; Wang, Y; Xiao, JH; Yan, YL; Yang, J | 1 |
Kavishankar, GB; Moree, SS; Rajesha, J | 1 |
Cho, EJ; Choi, JS; Chung, HY; Kim, HY; Yokozawa, T | 1 |
Kim, BK; Lee, HS; Lee, S; Lee, YS; Ohuchi, K; Shin, KH | 1 |
Chang, JC; Cheng, JT; Liu, IM; Wu, MC | 1 |
Beavers, MP; Bian, H; Conway, BR; Cox, GG; Demarest, KT; Patel, M; Rybczynski, PJ; Urbanski, M; Zeck, RE; Zhang, X | 1 |
Beppu, H; Chihara, T; Kaneko, T; Kuzuya, H; Ozaki, S; Shimpo, K; Sonoda, S; Tamai, I; Yamaji, S | 1 |
Che, CT; Cheng, CH; Lau, CB; Leung, PS; Li, JM | 1 |
Ashida, H; Fukuda, I; Horio, F; Hoshino, H; Ichi, T; Isa, Y; Kadowaki, M; Nishimura, N; Nishiumi, S; Sasaki, R; Tanaka, A; Tsuda, T | 1 |
Cheng, JT; Hsu, FL; Liu, IM; Niu, HS | 1 |
Cheng, JT; Hsu, FL; Lin, CL; Liu, IM; Niu, HS | 1 |
Jin, L; Jin, LJ; Li, SY; Xu, YP; Xue, HY | 1 |
Biller, SA; Deshpande, PP; Discenza, L; Ellsworth, BA; Flint, OP; Girotra, RN; Hagan, DL; Han, S; Humphreys, WG; Janovitz, EB; Khanna, A; McCann, PJ; Meng, W; Morgan, N; Morrison, EP; Nirschl, AA; Obermeier, MT; Patel, M; Pullockaran, A; Robertson, JG; Sher, PM; Taylor, JR; Wang, A; Washburn, WN; Wetterau, JR; Whaley, JM; Wu, G; Zahler, R | 1 |
Jin, L; Li, D; Lu, Y; Xia, Y; Xu, Y; Xue, H; Zhang, P | 1 |
Baynes, JW; Day, JF; Ingebretsen, CG; Ingebretsen, WR; Thorpe, SR | 1 |
Basnet, P; Kadota, S; Namba, T; Terashima, S | 1 |
Chansouria, JP; Jahromi, MA; Manickam, M; Ramanathan, M; Ray, AB | 1 |
Cheng, JT; Hsu, FL; Lai, CW | 1 |
Li, Y; Matsuda, H; Nishida, N; Shimada, H; Toguchida, I; Yamahara, J; Yoshikawa, M | 1 |
Anai, M; Arakawa, K; Asano, T; Endou, H; Ishihara, T; Kanai, Y; Kuronuma, Y; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
Anai, M; Arakawa, K; Asano, T; Kano-Ishihara, T; Matsumoto, M; Nawano, M; Oku, A; Saito, A; Tsujihara, K; Ueta, K | 1 |
Mantha, SV; Muir, AD; Prasad, K; Westcott, ND | 1 |
Adachi, T; Iwakura, I; Kitamura, K; Okamoto, Y; Oku, A; Saito, A; Seino, Y; Shihara, N; Tsuda, K; Ueta, K; Yamada, Y; Yano, H; Yasuda, K | 1 |
Adachi, T; Arakawa, K; Ikezawa, K; Kano-Ishihara, T; Matsumoto, T; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
Adachi, T; Arakawa, K; Kano-Ishihara, T; Matsumoto, M; Oku, A; Saito, A; Tsuda, K; Ueta, K; Yasuda, K | 1 |
Adanlawo, TA; Marquis, VO; Olaniyi, AA | 1 |
2 review(s) available for glucose, (beta-d)-isomer and Alloxan Diabetes
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
[Sodium-glucose cotransporter type 2 inhibitors (SGLT2): from familial renal glucosuria to the treatment of type 2 diabetes mellitus].
Topics: Absorption; Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dogs; Double-Blind Method; Gluconeogenesis; Glucose; Glucosides; Glycosuria, Renal; Homeostasis; Humans; Hypoglycemic Agents; Kidney; Kidney Tubules, Proximal; Mice; Phlorhizin; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2010 |
1 trial(s) available for glucose, (beta-d)-isomer and Alloxan Diabetes
Article | Year |
---|---|
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors.
Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses | 2021 |
257 other study(ies) available for glucose, (beta-d)-isomer and Alloxan Diabetes
Article | Year |
---|---|
Insulin resistance induced by zymosan as a new animal model in mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diet; Disease Models, Animal; Fructose; Insulin Resistance; Male; Mice; Mice, Inbred BALB C; Prediabetic State; Recovery of Function; Zymosan | 2013 |
Uncoupling protein-2 negatively regulates polymorphonuclear leukocytes chemotaxis via modulating [Ca2+] influx.
Topics: Animals; Calcium; CD11b Antigen; CD18 Antigens; Cell Movement; Chemotaxis; Cytoplasm; Diabetes Mellitus, Experimental; Disease Models, Animal; Ion Channels; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondrial Proteins; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Peritonitis; Streptozocin; Uncoupling Protein 2; Zymosan | 2010 |
Beneficial effects of troglitazone on neutrophil dysfunction in multiple low-dose streptozotocin-induced diabetic mice.
Topics: Animals; Ascitic Fluid; Blood Glucose; Cells, Cultured; Chemotaxis, Leukocyte; Chromans; Cytokines; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Male; Mice; Mice, Inbred ICR; Neutrophil Infiltration; Neutrophils; Phagocytosis; Superoxides; Tetradecanoylphorbol Acetate; Thiazolidinediones; Troglitazone; Zymosan | 2004 |
Reduced ability of neutrophils to produce active oxygen species in streptozotocin-induced diabetic rats.
Topics: Analysis of Variance; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Injections, Subcutaneous; Insulin; Luminescent Measurements; Luminol; Male; Neutrophils; Oxygen; Rats; Rats, Inbred Strains; Streptozocin; Zymosan | 1992 |
The hypoglycemic activity of endotoxin. I. Occurrence in animals hyperreactive to endotoxin.
Topics: Adrenal Glands; Adrenalectomy; Animals; Diabetes Mellitus, Experimental; Endotoxins; Female; Hypoglycemia; Mice; Mycobacterium bovis; Rabbits; Zymosan | 1969 |
Chebulagic acid attenuates HFD/streptozotocin induced impaired glucose metabolism and insulin resistance via up regulations of PPAR γ and GLUT 4 in type 2 diabetic rats.
Topics: Animals; Benzopyrans; Blood Glucose; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Hypoglycemic Agents; Insulin; Insulin Resistance; Liver; PPAR gamma; Rats; Rats, Wistar; Streptozocin | 2022 |
Phillyrin ameliorates diabetic nephropathy through the PI3K/Akt/GSK-3β signalling pathway in streptozotocin-induced diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glucosides; Glycogen Synthase Kinase 3 beta; Kidney; Male; Mice; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Random Allocation | 2021 |
Effects of GLP-1RA and SGLT2i, Alone or in Combination, on Mouse Models of Type 2 Diabetes Representing Different Disease Stages.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Therapy, Combination; Glucagon-Like Peptide-1 Receptor; Glucosides; Hypoglycemic Agents; Insulin-Secreting Cells; Liraglutide; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2021 |
Discovery of Salidroside-Derivated Glycoside Analogues as Novel Angiogenesis Agents to Treat Diabetic Hind Limb Ischemia.
Topics: Angiogenesis Inducing Agents; Animals; Diabetes Mellitus, Experimental; Glucosides; Glycosides; Hindlimb; Ischemia; Male; Mice; Mice, Inbred C57BL; Neovascularization, Pathologic; Phenols; Rats; Rats, Sprague-Dawley | 2022 |
Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes-Induced Atherosclerotic Plaque Instability.
Topics: Animals; Benzhydryl Compounds; Constriction, Pathologic; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucose; Glucosides; Humans; Hypoglycemic Agents; Mice; Plaque, Atherosclerotic; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2022 |
Dapagliflozin improves steatohepatitis in diabetic rats via inhibition of oxidative stress and inflammation.
Topics: Actins; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Liver; Glucosides; Insulin; Interleukin-1beta; Liver; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; Rats; Sodium-Glucose Transporter 2 Inhibitors; Transforming Growth Factor beta | 2022 |
Empagliflozin protects glomerular endothelial cell architecture in experimental diabetes through the VEGF-A/caveolin-1/PV-1 signaling pathway.
Topics: Albuminuria; Animals; Benzhydryl Compounds; Blood Glucose; Caveolin 1; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endothelial Cells; Female; Glomerular Basement Membrane; Glucosides; Humans; Male; Mice; Signal Transduction; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vascular Endothelial Growth Factor A | 2022 |
Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt/β-Catenin and CREB pathway.
Topics: Animals; Behavior, Animal; Benzhydryl Compounds; Cognitive Dysfunction; Cyclic AMP Response Element-Binding Protein; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Glycogen Synthase Kinase 3 beta; Memory Disorders; Neuroprotective Agents; Rats; Signal Transduction; Wnt3 Protein | 2022 |
The vascular impact of dapagliflozin, liraglutide, and atorvastatin alone or in combinations in type 2 diabetic rat model.
Topics: Animals; Atorvastatin; Benzhydryl Compounds; C-Reactive Protein; Cholesterol, LDL; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Glycated Hemoglobin; Liraglutide; Male; Pyrroles; Rats; Thyrotropin | 2022 |
The Effect of Sodium-Dependent Glucose Cotransporter 2 Inhibitor Tofogliflozin on Neurovascular Coupling in the Retina in Type 2 Diabetic Mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Glucosides; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Neurovascular Coupling; Retina; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Vascular Endothelial Growth Factor A | 2022 |
SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Heart Failure; Male; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Ipragliflozin attenuates non-alcoholic steatohepatitis development in an animal model.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Gene Expression Profiling; Gene Expression Regulation; Glucosides; Hepatocytes; Hypoglycemic Agents; Interleukin-1beta; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; Non-alcoholic Fatty Liver Disease; Signal Transduction; Streptozocin; Superoxide Dismutase; Thiophenes; Tumor Necrosis Factor-alpha | 2022 |
Effect of Empagliflozin on Sphingolipid Catabolism in Diabetic and Hypertensive Rats.
Topics: Animals; Benzhydryl Compounds; Ceramides; Diabetes Mellitus, Experimental; Glucosides; Humans; Hypertension; Rats; Sphingolipids; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2022 |
Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Glucosides; Humans; Inflammation; Liraglutide; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Long-Term Oral Administration of Salidroside Alleviates Diabetic Retinopathy in db/db Mice.
Topics: Administration, Oral; Animals; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Mice; Phenols | 2022 |
Paeoniflorin ameliorates diabetic liver injury by targeting the TXNIP-mediated NLRP3 inflammasome in db/db mice.
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fatty Liver; Glucosides; Inflammasomes; Mice; Molecular Docking Simulation; Monoterpenes; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Thioredoxins | 2022 |
Dapagliflozin Ameliorates Lipopolysaccharide Related Acute Kidney Injury in Mice with Streptozotocin-induced Diabetes Mellitus.
Topics: Acute Kidney Injury; AMP-Activated Protein Kinases; Animals; Benzhydryl Compounds; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Streptozocin | 2022 |
The sodium-glucose co-transporter 2 inhibitor tofogliflozin suppresses atherosclerosis through glucose lowering in ApoE-deficient mice with streptozotocin-induced diabetes.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Insulin; Interleukin-6; Mice; Mice, Knockout, ApoE; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2022 |
Preferential effect of Montelukast on Dapagliflozin: Modulation of IRS-1/AKT/GLUT4 and ER stress response elements improves insulin sensitivity in soleus muscle of a type-2 diabetic rat model.
Topics: Acetates; Animals; Antioxidants; Benzhydryl Compounds; Blood Glucose; Cyclopropanes; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum; Endoribonucleases; Glucose Transporter Type 4; Glucosides; Hypoglycemic Agents; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Leukotriene Antagonists; Metformin; Muscle, Skeletal; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Response Elements; Streptozocin; Sulfides | 2022 |
Empagliflozin prohibits high-fructose diet-induced cardiac dysfunction in rats via attenuation of mitochondria-driven oxidative stress.
Topics: Animals; Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Fibrosis; Fructose; Glucose; Glucosides; Heart Diseases; Insulin Resistance; Mitochondria; Oxidative Stress; Palmitates; Palmitic Acid; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: Role of oxidative stress, gut microbiota, and PPARγ activation.
Topics: Animals; Benzhydryl Compounds; Carotenoids; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gastrointestinal Microbiome; Glucosides; Lactobacillus; Male; Oxidative Stress; PPAR gamma; Rats; Rats, Wistar; Streptozocin | 2022 |
Polydatin prevents lipotoxicity-induced dysfunction in pancreatic β-cells by inhibiting endoplasmic reticulum stress and excessive autophagy.
Topics: Animals; Apoptosis; Autophagy; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Fatty Acids, Nonesterified; Glucosides; Insulin Resistance; Insulin-Secreting Cells; Mice; Palmitates; Stilbenes; Tunicamycin | 2022 |
Protective effect of salidroside on streptozotocin-induced diabetic nephropathy by inhibiting oxidative stress and inflammation in rats via the Akt/GSK-3β signalling pathway.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucosides; Glycogen Synthase Kinase 3 beta; Inflammation; Male; Oxidative Stress; Phenols; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Streptozocin | 2022 |
Gut microbiota profiling revealed the regulating effects of salidroside on iron metabolism in diabetic mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gastrointestinal Microbiome; Glucosides; Iron; Mice; Phenols; RNA, Ribosomal, 16S | 2022 |
Acteoside inhibits high glucose-induced oxidative stress injury in RPE cells and the outer retina through the Keap1/Nrf2/ARE pathway.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucose; Glucosides; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Polyphenols; Reactive Oxygen Species; Retina; Superoxide Dismutase | 2023 |
Metabolite profiling and biochemical investigation of the antidiabetic potential of Loranthus pulverulentus Wall n-butanol fraction in diabetic animal models.
Topics: 1-Butanol; Animals; Blood Glucose; Butanols; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glucosides; Glycated Hemoglobin; Glycogen; Hypoglycemic Agents; Insulin; Liver; Mice; Plant Extracts; Pyruvates; Streptozocin | 2024 |
The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucagon; Glucosides; Humans; Liraglutide; Male; Mice; Somatostatin | 2019 |
Acute and Direct Effects of Sodium-Glucose Cotransporter 2 Inhibition on Glomerular Filtration Rate in Spontaneously Diabetic Torii Fatty Rats.
Topics: Animals; Blood Glucose; Blood Pressure; Chlorides; Creatinine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glomerular Filtration Rate; Glucosides; Heart Rate; Male; Rats, Sprague-Dawley; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2019 |
Effects of ticagrelor, empagliflozin and tamoxifen against experimentally-induced vascular reactivity defects in rats in vivo and in vitro.
Topics: AMP-Activated Protein Kinase Kinases; Angiotensin II; Animals; Aorta; Arthritis, Rheumatoid; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Endothelium, Vascular; Female; Glucosides; Nitric Oxide; Nitric Oxide Synthase Type III; Protein Kinases; Purinergic P2 Receptor Antagonists; Rats; Rats, Inbred WF; Receptors, Purinergic P2Y12; Selective Estrogen Receptor Modulators; Sodium-Glucose Transporter 2 Inhibitors; Tamoxifen; Ticagrelor; Vascular Cell Adhesion Molecule-1; Vasodilation | 2019 |
Protective effects of Salidroside on spermatogenesis in streptozotocin induced type-1 diabetic male mice by inhibiting oxidative stress mediated blood-testis barrier damage.
Topics: Animals; Antioxidants; Blood-Testis Barrier; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Glutathione; Male; Malondialdehyde; Mice; Oxidative Stress; Phenols; Protective Agents; Reactive Oxygen Species; Sperm Count; Spermatogenesis; Spermatozoa; Streptozocin; Superoxide Dismutase; Testis | 2020 |
Melatonin ameliorates SGLT2 inhibitor-induced diabetic ketoacidosis by inhibiting lipolysis and hepatic ketogenesis in type 2 diabetic mice.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Ketoacidosis; Glucosides; Lipolysis; Male; Melatonin; Mice; Signal Transduction; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.
Topics: Animals; Atrial Fibrillation; Atrial Function, Left; Atrial Remodeling; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Models, Animal; Glucosides; Heart Rate; Male; Membrane Potential, Mitochondrial; Mitochondria, Heart; Mitochondrial Proteins; Organelle Biogenesis; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2019 |
SGLT2 inhibitor ipragliflozin alone and combined with pioglitazone prevents progression of nonalcoholic steatohepatitis in a type 2 diabetes rodent model.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Disease Progression; Drug Therapy, Combination; Glucosides; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Pioglitazone; Rodentia; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2019 |
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic mice.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Male; Mice; Mice, Inbred C57BL; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Ameliorative effect of polydatin on hyperglycemia and renal injury in streptozotocin-induced diabetic rats.
Topics: 3T3-L1 Cells; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; HEK293 Cells; Humans; Hyperglycemia; Inflammation; Mice; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Stilbenes | 2019 |
Sodium-glucose co-transporter 2 inhibition as a mitochondrial therapy for atrial fibrillation in patients with diabetes?
Topics: Animals; Atrial Fibrillation; Atrial Remodeling; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Glucose; Glucosides; Humans; Mitochondria; Rats; Sodium; Sodium-Glucose Transporter 2; Streptozocin | 2020 |
Lansoprazole enhances the antidiabetic effect of dapagliflozin in fortified diet-fed streptozotocin-treated diabetic rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Cholesterol; Diabetes Mellitus, Experimental; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Food, Fortified; Glucose Transporter Type 2; Glucosides; Hypoglycemic Agents; Inflammation Mediators; Insulin Resistance; Lansoprazole; Male; Oxidative Stress; Pancreas; PPAR gamma; Random Allocation; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Dysplastic urothelial changes accompany empagliflozin administration in urinary bladder of experimental diabetes.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucosides; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urothelium | 2019 |
Empagliflozin ameliorates endothelial dysfunction and suppresses atherogenesis in diabetic apolipoprotein E-deficient mice.
Topics: Adipose Tissue; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Eicosanoids; Endothelium, Vascular; Glucosides; Humans; Male; Mice; Mice, Knockout, ApoE; Plaque, Atherosclerotic; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2020 |
Reduced
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cell Hypoxia; Cell Line; Collagen; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Fibronectins; Fibrosis; Glucosides; Glycosylation; Humans; Kidney Tubules, Proximal; Male; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2020 |
Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules.
Topics: Animals; Benzhydryl Compounds; Canagliflozin; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epithelial-Mesenchymal Transition; Glucosides; Glycolysis; Kidney Tubules, Proximal; Male; Mice; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glucosides; Hypercholesterolemia; Hyperglycemia; Hypertriglyceridemia; Hypoglycemic Agents; Insulin; Male; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Liver Transcriptomic Reveals Novel Pathways of Empagliflozin Associated With Type 2 Diabetic Rats.
Topics: Animals; Benzhydryl Compounds; Carbohydrate Metabolism; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression Profiling; Genomics; Glucose; Glucosides; Liver; Male; Rats; Rats, Wistar; RNA-Seq; Signal Transduction; Transcriptome | 2020 |
Empagliflozin reduces vascular damage and cognitive impairment in a mixed murine model of Alzheimer's disease and type 2 diabetes.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzhydryl Compounds; Brain; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Female; Glucosides; Male; Mice; Mice, Transgenic | 2020 |
Structural dependence of antidiabetic effect of steviol glycosides and their metabolites on streptozotocin-induced diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diterpenes, Kaurane; Glucose; Glucosides; Humans; Hypoglycemic Agents; Kidney; Liver; Male; Mice; Mice, Inbred ICR; Plant Extracts; Plant Leaves; Stevia; Streptozocin | 2020 |
SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in
Topics: Animals; Apoptosis; Autophagy; Benzhydryl Compounds; Biomarkers; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidyl-Peptidase IV Inhibitors; Gene Expression; Glucosides; Immunohistochemistry; Kidney Function Tests; Kidney Glomerulus; Linagliptin; Mice; Mice, Inbred Strains; Mice, Transgenic; Podocytes; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats.
Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Glucosides; Kidney; Male; Myocardial Infarction; Rats | 2020 |
Empagliflozin improves left ventricular diastolic function of db/db mice.
Topics: Amino Acids, Branched-Chain; Animals; Benzhydryl Compounds; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Clinical Trials as Topic; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diet, High-Fat; Glucose; Glucosides; Humans; Hypoglycemic Agents; Ketone Bodies; Male; Mice; Mice, Transgenic; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Survival Analysis; Ventricular Function, Left | 2020 |
Dapagliflozin exerts positive effects on beta cells, decreases glucagon and does not alter beta- to alpha-cell transdifferentiation in mouse models of diabetes and insulin resistance.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Cell Transdifferentiation; Diabetes Mellitus, Experimental; Diet, High-Fat; Energy Intake; Glucagon; Glucagon-Secreting Cells; Glucosides; Homeodomain Proteins; Hydrocortisone; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice, Transgenic; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Trans-Activators | 2020 |
Early Intervention of Gastrodin Improved Motor Learning in Diabetic Rats Through Ameliorating Vascular Dysfunction.
Topics: Animals; Apoptosis; Behavior, Animal; Benzyl Alcohols; Cerebellar Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Endothelium, Vascular; Glucosides; Locomotion; Male; Nitric Oxide; Nitric Oxide Synthase; Purkinje Cells; Rats, Sprague-Dawley; Signal Transduction; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2020 |
Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model.
Topics: Animals; Benzhydryl Compounds; Biomechanical Phenomena; Bone Density; Bone Matrix; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Liraglutide; Mice; Osteogenesis | 2020 |
SIRT1 Activation by Polydatin Alleviates Oxidative Damage and Elevates Mitochondrial Biogenesis in Experimental Diabetic Neuropathy.
Topics: Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Mice; Mitochondria; Organelle Biogenesis; Oxidative Stress; Sirtuin 1; Stilbenes; Streptozocin | 2021 |
Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; C-Peptide; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Endocrine Cells; Glucagon; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Secreting Cells; Glucose; Glucosides; Insulin; Insulin-Secreting Cells; Male; Mice; Proprotein Convertase 1; Regeneration; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Polydatin attenuates renal fibrosis in diabetic mice through regulating the Cx32-Nox4 signaling pathway.
Topics: Animals; Connexins; Diabetes Mellitus, Experimental; Fibronectins; Fibrosis; Gap Junction beta-1 Protein; Glucosides; Intercellular Adhesion Molecule-1; Kidney; Male; Mice, Inbred C57BL; NADPH Oxidase 4; Oxidative Stress; Rats, Sprague-Dawley; Signal Transduction; Stilbenes; Ubiquitination | 2020 |
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucosides; GTP Cyclohydrolase; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2020 |
Pinoresinol-4-O-β-D-glucopyranoside: a lignan from prunes (Prunus domestica) attenuates oxidative stress, hyperglycaemia and hepatic toxicity in vitro and in vivo.
Topics: alpha-Amylases; alpha-Glucosidases; Animals; Antioxidants; Blood Glucose; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Diabetes Mellitus, Experimental; Fruit; Glucosides; Glycoside Hydrolase Inhibitors; Insulin; Lignans; Liver; Male; Mice; Molecular Docking Simulation; Oxidative Stress; Plant Extracts; Prunus domestica; Streptozocin | 2020 |
Empagliflozin reduces the senescence of cardiac stromal cells and improves cardiac function in a murine model of diabetes.
Topics: Animals; Benzhydryl Compounds; Biopsy; Cell Survival; Cellular Senescence; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucosides; Heart; Heart Failure; Inflammation; Male; Mice; Mice, Inbred C57BL; Myocardium; Sodium-Glucose Transporter 2; Stromal Cells; Ventricular Function, Left | 2020 |
The sodium-glucose cotransporter 2 inhibitor tofogliflozin prevents diabetic kidney disease progression in type 2 diabetic mice.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Male; Mice; Mice, Obese; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to Bench.
Topics: Aged; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Female; Glucosides; Humans; Male; Middle Aged; Myocardium; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2021 |
Paeoniflorin accelerates foot wound healing in diabetic rats though activating the Nrf2 pathway.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Foot; Diet, High-Fat; Disease Models, Animal; Gene Expression Regulation; Glucose; Glucosides; HaCaT Cells; Humans; Hypoglycemic Agents; Male; Monoterpenes; NF-E2-Related Factor 2; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A; Wound Healing | 2020 |
Cardioprotective effects of short-term empagliflozin treatment in db/db mice.
Topics: Animals; Benzhydryl Compounds; Body Weight; Cardiotonic Agents; Citrate (si)-Synthase; Cytokines; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, Western; Gene Expression Regulation; Glucosides; Male; Mice; Myocardium; Phosphorylation; Proto-Oncogene Proteins c-akt; Treatment Outcome | 2020 |
Dapagliflozin suppresses ER stress and protects doxorubicin-induced cardiotoxicity in breast cancer patients.
Topics: Adolescent; Adult; Aged; Animals; Antibiotics, Antineoplastic; Apoptosis; Benzhydryl Compounds; Breast Neoplasms; Cardiotoxicity; Caspase 3; Cell Line; Cell Survival; Comorbidity; Diabetes Complications; Diabetes Mellitus, Experimental; Disease Models, Animal; Doxorubicin; Echocardiography; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Female; Glucosides; Humans; Male; Middle Aged; Myocytes, Cardiac; Protective Agents; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Retrospective Studies; Young Adult | 2021 |
Paeoniflorin inhibited nod-like receptor protein-3 inflammasome and NF-κB-mediated inflammatory reactions in diabetic foot ulcer by inhibiting the chemokine receptor CXCR2.
Topics: Animals; Biomarkers; Cytokines; Diabetes Mellitus, Experimental; Diabetic Foot; Glucosides; Humans; Inflammasomes; Keratinocytes; Male; Monoterpenes; NF-kappa B; NLR Proteins; Rats; Rats, Sprague-Dawley; Receptors, Interleukin-8B; Signal Transduction; Wound Healing | 2021 |
Polydatin mitigates pancreatic β-cell damage through its antioxidant activity.
Topics: Animals; Antioxidants; Apoptosis; Blood Glucose; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Glucosides; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin-Secreting Cells; Lipid Peroxidation; Lipids; Male; Oxidative Stress; Rats, Wistar; Stilbenes | 2021 |
Cardioprotective effects of polydatin against myocardial injury in diabetic rats via inhibition of NADPH oxidase and NF-κB activities.
Topics: Animals; Cardiomyopathies; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Evaluation, Preclinical; Drugs, Chinese Herbal; Fallopia japonica; Glucosides; Heart; Male; Myocardium; NADPH Oxidases; NF-kappa B; Oxidative Stress; Rats, Sprague-Dawley; Stilbenes | 2020 |
SGLT2-i improves markers of islet endothelial cell function in db/db diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Drug Therapy, Combination; Endothelial Cells; Glucosides; Hypoglycemic Agents; Insulin Secretion; Islets of Langerhans; Male; Metformin; Mice; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Development and optimization of sitagliptin and dapagliflozin loaded oral self-nanoemulsifying formulation against type 2 diabetes mellitus.
Topics: Animals; Area Under Curve; Benzhydryl Compounds; Chemistry, Pharmaceutical; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Combinations; Drug Liberation; Emulsions; Glucosides; Hypoglycemic Agents; Male; Metabolic Clearance Rate; Mice; Microscopy, Electron, Transmission; Nanoparticles; Particle Size; Plant Oils; Rats; Rats, Wistar; Sitagliptin Phosphate; Solubility; Surface Properties | 2021 |
Polydatin and polydatin-loaded chitosan nanoparticles attenuate diabetic cardiomyopathy in rats.
Topics: Animals; Antioxidants; Chitosan; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucosides; Glycated Hemoglobin; Immunohistochemistry; Male; Nanoparticles; Oxidative Stress; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Stilbenes | 2021 |
Steviol Glycosides Supplementation Affects Lipid Metabolism in High-Fat Fed STZ-Induced Diabetic Rats.
Topics: Animals; Biomarkers; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dietary Supplements; Diterpenes, Kaurane; Glucosides; Lipid Metabolism; Male; Rats; Rats, Wistar | 2020 |
Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Glomerular Filtration Rate; Glucosides; Hyperglycemia; Male; Obesity; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Salidroside alleviates diabetic neuropathic pain through regulation of the AMPK-NLRP3 inflammasome axis.
Topics: AMP-Activated Protein Kinases; Analgesics; Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Ganglia, Spinal; Glucosides; Hypoglycemic Agents; Inflammasomes; Insulin Resistance; Male; Neuralgia; NLR Family, Pyrin Domain-Containing 3 Protein; Oxidative Stress; Pain Threshold; Phenols; Rats, Sprague-Dawley; Signal Transduction | 2021 |
The SGLT2 inhibitor empagliflozin negatively regulates IL-17/IL-23 axis-mediated inflammatory responses in T2DM with NAFLD via the AMPK/mTOR/autophagy pathway.
Topics: AMP-Activated Protein Kinases; Animals; Autophagy; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Interleukin-17; Interleukin-23; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RAW 264.7 Cells; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; TOR Serine-Threonine Kinases | 2021 |
Dapagliflozin reverses the imbalance of T helper 17 and T regulatory cells by inhibiting SGK1 in a mouse model of diabetic kidney disease.
Topics: Animals; Benzhydryl Compounds; China; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Glucosides; Immediate-Early Proteins; Male; Mice; Mice, Inbred C57BL; Protein Serine-Threonine Kinases; T-Lymphocytes, Regulatory; Th17 Cells | 2021 |
Dapagliflozin elevates plasma high-density lipoprotein levels and influences visceral fat gene expression in streptozotocin-induced diabetes mellitus.
Topics: Adipose Tissue; Administration, Oral; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucosides; Hypoglycemic Agents; Intra-Abdominal Fat; Lipids; Lipoproteins, HDL; Male; Rats; Rats, Wistar; Streptozocin | 2021 |
Protective effect of flavonoids from Passiflora edulis Sims on diabetic complications in rats.
Topics: Animals; Antioxidants; Apigenin; Blood Glucose; Chromatography, High Pressure Liquid; Diabetes Complications; Diabetes Mellitus, Experimental; Flavones; Flavonoids; Fructosamine; Glucosides; Glycosides; Luteolin; Male; Passiflora; Phytotherapy; Plant Extracts; Plant Leaves; Platelet Aggregation; Rats, Wistar; Tandem Mass Spectrometry | 2021 |
Hepatoprotective Effects of Polydatin-Loaded Chitosan Nanoparticles in Diabetic Rats: Modulation of Glucose Metabolism, Oxidative Stress, and Inflammation Biomarkers.
Topics: Animals; Chitosan; Diabetes Mellitus, Experimental; Glucose; Glucosides; Inflammation; Lipid Peroxidation; Liver; Male; Metformin; Nanoparticles; Niacinamide; Oxidative Stress; Protective Agents; Rats; Rats, Wistar; Stilbenes; Streptozocin | 2021 |
Effect of syringin (eleutheroside B) on the physiological and hematological parameters in STZ induced Type II diabetic Wistar rats.
Topics: Administration, Oral; Animals; Blood Cell Count; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drinking; Glucosides; Hypoglycemic Agents; Male; Phenylpropionates; Rats, Wistar; Streptozocin | 2020 |
Inhibition of SGLT2 Rescues Bone Marrow Cell Traffic for Vascular Repair: Role of Glucose Control and Ketogenesis.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Bone Marrow Cells; Diabetes Mellitus, Experimental; Glucosides; Hematopoietic Stem Cells; Human Umbilical Vein Endothelial Cells; Humans; Mice; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction.
Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electrocardiography; Glucosides; Kidney; Lipocalin-2; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Empagliflozin ameliorates symptoms of diabetes and renal tubular dysfunction in a rat model of diabetes with enlarged kidney (DEK).
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hyperglycemia; Kidney; Kidney Diseases; Male; Rats; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Synergistic cardioptotection by tilianin and syringin in diabetic cardiomyopathy involves interaction of TLR4/NF-κB/NLRP3 and PGC1a/SIRT3 pathways.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Drug Synergism; Flavonoids; Glucosides; Glycosides; Inflammasomes; Male; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenylpropionates; Rats; Rats, Sprague-Dawley; Signal Transduction; Sirtuins; Toll-Like Receptor 4 | 2021 |
The sodium-glucose cotransporter-2 inhibitor Tofogliflozin prevents the progression of nonalcoholic steatohepatitis-associated liver tumors in a novel murine model.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cellular Senescence; Diabetes Mellitus, Experimental; Diet, Western; Disease Models, Animal; Disease Progression; Glucosides; Hepatocytes; Insulin; Liver; Liver Neoplasms; Mice, Inbred C57BL; Mice, Knockout; Non-alcoholic Fatty Liver Disease; Obesity; Receptor, Melanocortin, Type 4; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Salidroside protects cardiac function in mice with diabetic cardiomyopathy via activation of mitochondrial biogenesis and SIRT3.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Glucosides; Mice; Mitochondria; Myocytes, Cardiac; Organelle Biogenesis; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Phenols; Rats; Sirtuin 3 | 2021 |
Polydatin protects Schwann cells from methylglyoxal induced cytotoxicity and promotes crushed sciatic nerves regeneration of diabetic rats.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Glucosides; Kelch-Like ECH-Associated Protein 1; Nerve Crush; NF-E2-Related Factor 2; Pyruvaldehyde; Rats; Schwann Cells; Sciatic Nerve; Stilbenes | 2021 |
Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL/6NCrl mice with high-fat diet/streptozotocin-induced diabetes mellitus.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; DNA, Mitochondrial; Dynamins; Gene Dosage; Glucosides; GTP Phosphohydrolases; Lipid Peroxidation; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Obesity; Oxidative Phosphorylation; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Random Allocation; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2021 |
Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Topics: AMP-Activated Protein Kinases; Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diet, High-Fat; Disease Models, Animal; Epithelial-Mesenchymal Transition; Fibroblasts; Fibrosis; Glucosides; Male; Mesoderm; Rats; Signal Transduction; Smad4 Protein; Sodium-Glucose Transporter 2 Inhibitors; Transforming Growth Factor beta | 2021 |
Impact of sodium glucose linked cotransporter-2 inhibition on renal microvascular oxygen tension in a rodent model of diabetes mellitus.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Erythropoietin; Glomerular Filtration Rate; Glucosides; Kidney; Male; Microvessels; Oxygen; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Human and mouse non-targeted metabolomics identify 1,5-anhydroglucitol as SGLT2-dependent glycemic marker.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Humans; Metabolome; Mice; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Ipragliflozin Ameliorates Diabetic Nephropathy Associated with Perirenal Adipose Expansion in Mice.
Topics: Adipose Tissue; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucosides; Kidney Glomerulus; Male; Mice; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2021 |
Dapagliflozin attenuates diabetic cardiomyopathy through erythropoietin up-regulation of AKT/JAK/MAPK pathways in streptozotocin-induced diabetic rats.
Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Electrocardiography; Erythropoietin; Glucosides; Male; MAP Kinase Signaling System; Myocardium; Rats, Wistar; Streptozocin | 2021 |
Paeoniflorin ameliorates cognitive dysfunction via regulating SOCS2/IRS-1 pathway in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blood Glucose; Cognition Disorders; Cytokines; Diabetes Mellitus, Experimental; Disease Models, Animal; Dose-Response Relationship, Drug; Glucosides; Hippocampus; Insulin Receptor Substrate Proteins; Male; Maze Learning; Monoterpenes; Phosphorylation; Random Allocation; Rats; Rats, Sprague-Dawley; Signal Transduction; Suppressor of Cytokine Signaling Proteins; tau Proteins | 2017 |
Insight into anti-diabetic effect of low dose of stevioside.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diterpenes, Kaurane; Glucose Tolerance Test; Glucosides; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Mice; Phytotherapy; Plant Extracts; Stevia | 2017 |
Effect of Empagliflozin on Tacrolimus-Induced Pancreas Islet Dysfunction and Renal Injury.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Humans; Hypoglycemic Agents; Insulin; Islets of Langerhans; Kidney; Male; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sodium-Glucose Transporter 2; Tacrolimus | 2017 |
Salidroside contributes to reducing blood pressure and alleviating cerebrovascular contractile activity in diabetic Goto-Kakizaki Rats by inhibition of L-type calcium channel in smooth muscle cells.
Topics: Animals; Blood Glucose; Blood Pressure; Calcium Channels, L-Type; Cells, Cultured; Cerebral Arteries; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Gene Expression Regulation; Glucosides; Hypoglycemic Agents; Male; Muscle Contraction; Muscle, Smooth, Vascular; Phenols; Rats, Inbred WKY; RNA, Messenger; Vasodilation | 2017 |
The Sodium-Glucose Co-Transporter 2 Inhibitor, Empagliflozin, Protects against Diabetic Cardiomyopathy by Inhibition of the Endoplasmic Reticulum Stress Pathway.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Down-Regulation; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Glucosides; Heat-Shock Proteins; Hemodynamics; Male; Myocardium; Myocytes, Cardiac; Protective Agents; Rats; Rats, Wistar; Sodium-Glucose Transport Proteins; TNF Receptor-Associated Factor 2; Transcription Factor CHOP | 2017 |
CHEMICAL CHARACTERIZATION OF A HYPOGLYCEMIC EXTRACT FROM
Topics: Alloxan; Animals; Benzyl Alcohols; Coumaric Acids; Cucurbita; Diabetes Mellitus, Experimental; Glucosides; Hydroxybenzoates; Hypoglycemic Agents; Insulin; Liver; Liver Glycogen; Male; Mice; Phytochemicals; Phytotherapy; Plant Extracts; Propionates; Sitosterols | 2017 |
Dapagliflozin suppresses glucagon signaling in rodent models of diabetes.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Glucagon; Glucagon-Secreting Cells; Glucose; Glucosides; Hypoglycemic Agents; Kidney Tubules, Proximal; Male; Mice; Rats; Rats, Sprague-Dawley; Rats, Zucker; Rodentia; Signal Transduction; Sodium-Glucose Transporter 2 | 2017 |
Metabolic and neuroprotective effects of dapagliflozin and liraglutide in diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Like Peptide 1; Glucagon-Secreting Cells; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Interleukin-6; Liraglutide; Male; Mice; Neurons; Neuroprotective Agents | 2017 |
Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Calcium-Binding Proteins; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Hypoglycemic Agents; Male; Mice; Models, Genetic; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Ventricular Dysfunction, Left | 2017 |
Insulin stimulates uric acid reabsorption via regulating urate transporter 1 and ATP-binding cassette subfamily G member 2.
Topics: Animals; Anion Transport Proteins; ATP Binding Cassette Transporter, Subfamily G, Member 2; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Hypoglycemic Agents; Insulin; Kidney Tubules; Male; Rats, Sprague-Dawley; Renal Elimination; Renal Reabsorption; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes; Time Factors; Uric Acid | 2017 |
[Chemical constituents of Myripnois dioica].
Topics: Animals; Apigenin; Asteraceae; Diabetes Mellitus, Experimental; Flavonoids; Glucosides; Luteolin; Mice; Phytochemicals | 2016 |
Circulating microRNA-375 as biomarker of pancreatic beta cell death and protection of beta cell mass by cytoprotective compounds.
Topics: Animals; Apoptosis; Biomarkers; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Exenatide; Glucosides; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Mice; Mice, Inbred BALB C; MicroRNAs; Pancreas; Peptides; Phenylpropionates; Protective Agents; Streptozocin; Venoms | 2017 |
Hepatoprotective effect of peony total glucosides and the underlying mechanisms in diabetic rats.
Topics: Animals; Diabetes Mellitus, Experimental; Glucosides; Liver; Male; Paeonia; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Treatment Outcome | 2017 |
Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.
Topics: Administration, Intravenous; Administration, Oral; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucose; Glucosides; Humans; Hypoglycemic Agents; Molecular Structure; Monosaccharides; Oximes; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship | 2018 |
[Triperygium wilfordii multiglucoside ameliorates kidney damage in diabetic rats by inhibiting the expressions of MBL and MASP2].
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Gene Expression; Glucosides; Male; Mannose-Binding Lectin; Mannose-Binding Protein-Associated Serine Proteases; Phytotherapy; Plant Preparations; Rats, Sprague-Dawley; Tripterygium | 2017 |
Anthocyanins inhibit high glucose-induced renal tubular cell apoptosis caused by oxidative stress in db/db mice.
Topics: Albuminuria; Animals; Anthocyanins; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Body Weight; Carrier Proteins; Cell Line; Creatinine; Diabetes Mellitus, Experimental; Fasting; Glucose; Glucosides; Grape Seed Extract; Humans; Kidney Tubules; Male; MAP Kinase Signaling System; Membrane Potential, Mitochondrial; Mice, Inbred C57BL; Oxidative Stress; Phosphorylation; Proanthocyanidins; Reactive Oxygen Species; Thioredoxins; Triglycerides; Urea | 2018 |
Effects of the SGLT2 inhibitor ipragliflozin on various diabetic symptoms and progression of overt nephropathy in type 2 diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucose; Glucosides; Hypoglycemic Agents; Kidney; Male; Mice, Inbred ICR; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Oroxin A from Oroxylum indicum prevents the progression from prediabetes to diabetes in streptozotocin and high-fat diet induced mice.
Topics: alpha-Glucosidases; Animals; Antioxidants; Bignoniaceae; Diabetes Mellitus, Experimental; Diet, High-Fat; Flavones; Glucosides; Glycoside Hydrolase Inhibitors; Humans; Lipid Metabolism; Liver; Male; Mice; Oxidative Stress; PPAR gamma; Prediabetic State; Seeds; Streptozocin | 2018 |
Antidiabetic effects of SGLT2 inhibitor ipragliflozin in type 2 diabetic mice fed diets containing different carbohydrate contents.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet; Dietary Carbohydrates; Glucosides; Hypoglycemic Agents; Mice; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Dapagliflozin Aggravates Renal Injury via Promoting Gluconeogenesis in db/db Mice.
Topics: Animals; Area Under Curve; Benzhydryl Compounds; Blood Glucose; Blood Urea Nitrogen; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Gluconeogenesis; Glucose; Glucose Tolerance Test; Glucosides; Insulin; Kidney; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Microscopy, Electron, Transmission; ROC Curve; Signal Transduction | 2018 |
SGLT2 inhibition reduces atherosclerosis by enhancing lipoprotein clearance in Ldlr
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter, Subfamily G, Member 5; ATP Binding Cassette Transporter, Subfamily G, Member 8; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cholesterol, Dietary; Cytochrome P-450 Enzyme System; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Glucosides; Heparin; Hyperlipidemias; Lipoproteins; Liver; Male; Mice, Inbred C57BL; Mice, Knockout; Monocytes; Phlorhizin; Proteoglycans; Receptors, LDL; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2018 |
Renal protective effect of Paeoniflorin by inhibition of JAK2/STAT3 signaling pathway in diabetic mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Glucosides; Humans; Janus Kinase 2; Kidney; Macrophages; Male; Mice; Mice, Inbred C57BL; Monoterpenes; Signal Transduction; STAT3 Transcription Factor; Streptozocin | 2018 |
Prevention of progression of diabetic nephropathy by the SGLT2 inhibitor ipragliflozin in uninephrectomized type 2 diabetic mice.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Hypertension; Kidney; Losartan; Male; Mice, Inbred C57BL; Nephrectomy; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Protective Effect of Ipragliflozin on Pancreatic Islet Cells in Obese Type 2 Diabetic db/db Mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Acids; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Islets of Langerhans; Lipid Metabolism; Male; Mice; Mice, Obese; Obesity; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triglycerides | 2018 |
Insulin dependent and independent normalization of blood glucose levels reduces the enhanced rewarding effects of nicotine in a rodent model of diabetes.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Conditioning, Psychological; Diabetes Mellitus, Experimental; Female; Glucosides; Hyperglycemia; Hypoglycemic Agents; Insulin; Male; Nicotine; Nicotinic Agonists; Reward | 2018 |
Cyanidin-3-O-glucoside ameliorates diabetic nephropathy through regulation of glutathione pool.
Topics: Animals; Anthocyanins; Buthionine Sulfoximine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibrosis; Glucose; Glucosides; Glutathione; Inflammation; Kidney; Lipid Metabolism; Male; Mice, Inbred C57BL; Obesity; Protective Agents | 2018 |
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.
Topics: Animals; Autophagy; Benzhydryl Compounds; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Proteins; Mitochondrial Size; Myocardial Infarction; Myocytes, Cardiac; Rats, Inbred OLETF; Reactive Oxygen Species; Sodium-Glucose Transporter 2 Inhibitors; Triglycerides; Vacuoles | 2018 |
Effects of the SGLT2 inhibitor ipragliflozin on food intake, appetite-regulating hormones, and arteriovenous differences in postprandial glucose levels in type 2 diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Eating; Ghrelin; Glucosides; Hypoglycemic Agents; Male; Postprandial Period; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Treatment Outcome | 2018 |
Sodium-glucose cotransporter 2 inhibition normalizes glucose metabolism and suppresses oxidative stress in the kidneys of diabetic mice.
Topics: Animals; Blood Glucose; Caloric Restriction; Citric Acid Cycle; Diabetes Mellitus, Experimental; Glucose; Glucosides; Kidney; Male; Mice; Mice, Obese; Oxidative Stress; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2018 |
Effect of Dapagliflozin on Intestinal Flora in MafA-deficient Mice.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Benzhydryl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Gastrointestinal Microbiome; Glucosides; Maf Transcription Factors, Large; Male; Mice; Mice, Inbred ICR; Streptozocin | 2018 |
Inhibitory effect of Ligustrum vulgare leaf extract on the development of neuropathic pain in a streptozotocin-induced rat model of diabetes.
Topics: Aldehydes; Animals; Chromatography, High Pressure Liquid; Cyclopentane Monoterpenes; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glucosides; Glycosides; Hyperalgesia; Iridoid Glucosides; Iridoids; Ligustrum; Male; Neuralgia; Phenols; Plant Extracts; Plant Leaves; Rats; Streptozocin | 2018 |
Empagliflozin reduces myocardial ketone utilization while preserving glucose utilization in diabetic hypertensive heart disease: A hyperpolarized
Topics: Animals; Benzhydryl Compounds; Blood Pressure; Carbon-13 Magnetic Resonance Spectroscopy; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glucose; Glucosides; Heart; Ketones; Male; Myocardium; Obesity; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Weight Gain | 2019 |
Fibroblast growth factor 21 regulates glucose metabolism in part by reducing renal glucose reabsorption.
Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Fibroblast Growth Factors; Glucose; Glucosides; Homeostasis; Humans; Hyperglycemia; Insulin; Insulin Resistance; Kidney; Male; Mice; Mice, Inbred C57BL; PPAR delta; Sodium-Glucose Transporter 2 | 2018 |
Early administration of dapagliflozin preserves pancreatic β-cell mass through a legacy effect in a mouse model of type 2 diabetes.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Glucosides; Insulin; Insulin-Secreting Cells; Male; Mice; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Syringaresinol‑di‑O‑β‑D‑glucoside, a phenolic compound from Polygonatum sibiricum, exhibits an antidiabetic and antioxidative effect on a streptozotocin‑induced mouse model of diabetes.
Topics: Animals; Antioxidants; Biomarkers; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; Fasting; Glucosides; Hypoglycemic Agents; Insulin; Kidney; Lignans; Liver; Male; Mice; Plant Extracts; Polygonatum | 2018 |
Salidroside prevents diabetes‑induced cognitive impairment via regulating the Rho pathway.
Topics: Animals; Apoptosis; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucosides; Male; Oxidative Stress; Phenols; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction | 2019 |
Tetrahydroxy stilbene glucoside protected against diabetes-induced osteoporosis in mice with streptozotocin-induced hyperglycemia.
Topics: Animals; Bone and Bones; Diabetes Mellitus, Experimental; Femur; Glucosides; Hyperglycemia; Male; Mice; Mice, Inbred C57BL; Osteoblasts; Osteoclasts; Osteogenesis; Osteoporosis; Renin-Angiotensin System; Stilbenes; Streptozocin; Tartrate-Resistant Acid Phosphatase | 2019 |
First-dose effect of the SGLT2 inhibitor ipragliflozin on cardiovascular activity in spontaneously diabetic Torii fatty rats.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Cardiovascular System; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucosides; Heart Rate; Rats; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Urinalysis | 2019 |
Dapagliflozin attenuates early markers of diabetic nephropathy in fructose-streptozotocin-induced diabetes in rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fructose; Glucosides; Male; Pilot Projects; Random Allocation; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2019 |
Action of corilagin on hyperglycemia, hyperlipidemia and oxidative stress in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Glucosides; Glutathione; Glycated Hemoglobin; Hydrolyzable Tannins; Hyperglycemia; Hyperlipidemias; Insulin; Lipids; Male; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase | 2019 |
Long-Term Treatment with Empagliflozin Attenuates Renal Damage in Obese Zucker Rat.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Administration Schedule; Glucosides; Kidney; Maintenance Chemotherapy; Male; Obesity; Rats; Rats, Zucker; Time Factors | 2020 |
Salidroside-Pretreated Mesenchymal Stem Cells Enhance Diabetic Wound Healing by Promoting Paracrine Function and Survival of Mesenchymal Stem Cells Under Hyperglycemia.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Paracrine Communication; Phenols; Survival Rate; Wound Healing | 2019 |
Resveratroloside Alleviates Postprandial Hyperglycemia in Diabetic Mice by Competitively Inhibiting α-Glucosidase.
Topics: alpha-Glucosidases; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Male; Mice; Molecular Docking Simulation; Stilbenes | 2019 |
Effect of Dapagliflozin Treatment on the Expression of Renal Sodium Transporters/Channels on High-Fat Diet Diabetic Mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diet, High-Fat; Glucosides; Male; Membrane Transport Proteins; Mice; Sodium; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Potassium-Exchanging ATPase; Streptozocin | 2019 |
Early intervention with gastrodin reduces striatal neurotoxicity in adult rats with experimentally‑induced diabetes mellitus.
Topics: Animals; Benzyl Alcohols; Biomarkers; Brain-Derived Neurotrophic Factor; Corpus Striatum; Diabetes Mellitus, Experimental; Gene Expression; Glucosides; Glutamic Acid; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Biological; Neurons; Rats; Receptor, trkB | 2019 |
Hyperglycemia induces skeletal muscle atrophy via a WWP1/KLF15 axis.
Topics: Animals; Benzhydryl Compounds; Chlorocebus aethiops; COS Cells; Diabetes Mellitus, Experimental; Down-Regulation; Female; Gene Expression Profiling; Glucosides; HEK293 Cells; Humans; Hyperglycemia; Kruppel-Like Transcription Factors; Male; Mice; Mice, Knockout; Muscle, Skeletal; Muscular Atrophy; Proteolysis; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Ubiquitin-Protein Ligases; Up-Regulation | 2019 |
Ameliorative Effect and Mechanism of the Purified Anthraquinone-Glycoside Preparation from
Topics: Animals; Anthraquinones; Antioxidants; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Hypoglycemic Agents; Lipid Metabolism; Liver; Male; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Rheum; Superoxide Dismutase | 2019 |
A Protective Role of Paeoniflorin in Fluctuant Hyperglycemia-Induced Vascular Endothelial Injuries through Antioxidative and Anti-Inflammatory Effects and Reduction of PKC
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucosides; Human Umbilical Vein Endothelial Cells; Humans; Hyperglycemia; Inflammation; Male; Monoterpenes; Oxidative Stress; Protective Agents; Protein Kinase C beta; Rats, Sprague-Dawley; Vascular System Injuries | 2019 |
Modulatory effect of empagliflozin on cellular parameters of endocrine pancreas in experimental pre-diabetes.
Topics: Animals; Area Under Curve; Benzhydryl Compounds; Blood Glucose; Caspase 3; Cell Proliferation; Cytokines; Diabetes Mellitus, Experimental; Glucagon; Glucagon-Secreting Cells; Glucose Tolerance Test; Glucosides; Homeostasis; Immunohistochemistry; Insulin-Secreting Cells; Islets of Langerhans; Male; Prediabetic State; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
A novel SGLT2 inhibitor, SU-011, improves glycaemic control in rodents without the risk of hypoglycaemia and weight gain.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; C-Reactive Protein; Diabetes Mellitus, Experimental; Glucosides; HEK293 Cells; Humans; Interleukin-1beta; Male; Mice; Peptide Fragments; Pyrans; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Tumor Necrosis Factor-alpha | 2019 |
Sodium Glucose Cotransporter 2 Inhibition and the Visualization of Kidney Hemodynamics.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucosides; Hemodynamics; Mice; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Role of glucose transporters in the intestinal absorption of gastrodin, a highly water-soluble drug with good oral bioavailability.
Topics: Animals; Benzyl Alcohols; Biological Availability; Caco-2 Cells; Cell Line, Tumor; Diabetes Mellitus, Experimental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 1; Solubility | 2013 |
Hypoglycemic action of borapetoside A from the plant Tinospora crispa in mice.
Topics: Animals; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Diterpenes; Gluconeogenesis; Glucose; Glucosides; Glycogen; Hypoglycemic Agents; Insulin; Interleukin-6; Liver; Male; Mice; Mice, Inbred ICR; Muscles; Phosphoenolpyruvate Carboxykinase (GTP); Phytotherapy; Plant Extracts; Plants, Medicinal; Signal Transduction; Tinospora | 2013 |
Supplementation of cyanidin-3-O-β-glucoside promotes endothelial repair and prevents enhanced atherogenesis in diabetic apolipoprotein E-deficient mice.
Topics: Acetylcholine; AMP-Activated Protein Kinases; Animals; Anthocyanins; Aorta; Apolipoproteins E; Atherosclerosis; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Diet; Dietary Supplements; Endothelial Cells; Endothelium; Glucosides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; Stem Cells; Streptozocin; Wound Healing | 2013 |
Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid, an α-hydroxy acid from rooibos (Aspalathus linearis) with hypoglycemic activity.
Topics: Animals; Aspalathus; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Gene Expression Regulation; Glucose; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin Resistance; Liver; Male; Muscle, Skeletal; Obesity; Phenylpropionates; Rats; Rats, Wistar | 2013 |
Combined antidiabetic benefits of exenatide and dapagliflozin in diabetic mice.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Exenatide; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Male; Mice; Mice, Inbred NOD; Peptides; Venoms | 2014 |
Effects of total glucosides of paeony on immune regulatory toll-like receptors TLR2 and 4 in the kidney from diabetic rats.
Topics: Albumins; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucosides; Kidney; Macrophages; Male; Myeloid Differentiation Factor 88; Paeonia; Phytotherapy; Plant Extracts; Rats, Wistar; RNA, Messenger; Toll-Like Receptor 2; Toll-Like Receptor 4 | 2014 |
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Fatty Liver; Glomerular Filtration Rate; Glucose Intolerance; Glucosides; Hyperglycemia; Hyperlipidemias; Hypoglycemic Agents; Inflammation; Kidney; Liver; Male; Oxidative Stress; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes | 2014 |
Total glucosides of paeony attenuate renal tubulointerstitial injury in STZ-induced diabetic rats: role of Toll-like receptor 2.
Topics: Actins; Administration, Oral; Animals; Anti-Inflammatory Agents; Biomarkers; Cadherins; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucosides; Immunohistochemistry; Kidney; Macrophage Activation; Male; Molecular Conformation; Nephritis, Interstitial; NF-kappa B; Paeonia; Phytotherapy; Rats; Rats, Wistar; Streptozocin; Toll-Like Receptor 2 | 2014 |
8-O-acetyl shanzhiside methylester attenuates cerebral ischaemia/reperfusion injury through an anti-inflammatory mechanism in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents; Blood-Brain Barrier; Brain Ischemia; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucosides; HMGB1 Protein; Male; NF-kappa B; Peroxidase; Pyrans; Rats, Sprague-Dawley; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2014 |
Comparative pharmacokinetic investigation on baicalin and wogonoside in type 2 diabetic and normal rats after oral administration of traditional Chinese medicine Huanglian Jiedu decoction.
Topics: Administration, Oral; Animals; Area Under Curve; Chromatography, High Pressure Liquid; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Flavanones; Flavonoids; Glucosides; Hypolipidemic Agents; Male; Medicine, Chinese Traditional; Plant Extracts; Rats; Rats, Sprague-Dawley; Scutellaria baicalensis | 2014 |
Metformin supports the antidiabetic effect of a sodium glucose cotransporter 2 inhibitor by suppressing endogenous glucose production in diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Disease Models, Animal; Drug Therapy, Combination; Glucose; Glucose Clamp Technique; Glucosides; Glycated Hemoglobin; Hyperglycemia; Hypoglycemic Agents; Metformin; Mice, Knockout; Mice, Obese; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Isoindoles; Niacinamide; Rats; Rats, Zucker; Streptozocin | 2015 |
Polydatin promotes Nrf2-ARE anti-oxidative pathway through activating Sirt1 to resist AGEs-induced upregulation of fibronetin and transforming growth factor-β1 in rat glomerular messangial cells.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Gene Silencing; Glucosides; Glycation End Products, Advanced; Mesangial Cells; NF-E2-Related Factor 2; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Response Elements; Sirtuin 1; Stilbenes; Transforming Growth Factor beta1; Up-Regulation | 2015 |
Analysis of the effect of canagliflozin on renal glucose reabsorption and progression of hyperglycemia in zucker diabetic Fatty rats.
Topics: Animals; Blood Glucose; Canagliflozin; Diabetes Mellitus, Experimental; Dogs; Glucose; Glucosides; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Islets of Langerhans; Kidney; Mice; Rats; Rats, Zucker; Sodium-Glucose Transporter 2; Thiophenes | 2014 |
Polydatin improves glucose and lipid metabolism in experimental diabetes through activating the Akt signaling pathway.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Glucokinase; Glucose; Glucose-6-Phosphatase; Glucosides; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, LDL; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Stilbenes | 2014 |
Secoisolariciresinol diglucoside in high-fat diet and streptozotocin-induced diabetic nephropathy in rats: a possible renoprotective effect.
Topics: Animals; Apoptosis; Butylene Glycols; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Drug Evaluation, Preclinical; Glucosides; Hypoglycemic Agents; Kidney; Male; Microtubule-Associated Proteins; Nitric Oxide Synthase Type II; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats, Sprague-Dawley; Streptozocin; Survivin; Tumor Necrosis Factor-alpha | 2014 |
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiovascular Diseases; Cognition Disorders; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Hypoglycemic Agents; Male; Mice, Inbred C57BL; Obesity; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2014 |
Exploiting the therapeutic potential of 8-β-d-glucopyranosylgenistein: synthesis, antidiabetic activity, and molecular interaction with islet amyloid polypeptide and amyloid β-peptide (1-42).
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzothiazoles; Diabetes Mellitus, Experimental; Drug Design; Epitopes; Genista; Genistein; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Magnetic Resonance Spectroscopy; Microscopy, Atomic Force; Microscopy, Fluorescence; Oxygen; Protein Binding; Protein Conformation; Protein Kinase Inhibitors; Rats; Rats, Wistar; Streptozocin; Thiazoles | 2014 |
Dapagliflozin reduces the amplitude of shortening and Ca(2+) transient in ventricular myocytes from streptozotocin-induced diabetic rats.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Calcium; Diabetes Mellitus, Experimental; Glucose; Glucosides; Heart Ventricles; Humans; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Streptozocin | 2015 |
Inhibition of kidney proximal tubular glucose reabsorption does not prevent against diabetic nephropathy in type 1 diabetic eNOS knockout mice.
Topics: Albuminuria; Animals; Benzhydryl Compounds; Benzimidazoles; Benzoates; Blood Glucose; Chemokine CCL2; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibronectins; Glucose Transporter Type 1; Glucosides; Hypoglycemic Agents; Kidney Tubules, Proximal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide Synthase Type III; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Telmisartan; Toll-Like Receptor 2; Transforming Growth Factor beta1 | 2014 |
The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cytokines; Diabetes Complications; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Gene Expression; Glucose; Glucosides; Hemodynamics; Inflammation Mediators; Insulin; Male; Oxidative Stress; Rats; Receptor for Advanced Glycation End Products; Receptors, Immunologic; RNA, Messenger; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2014 |
C-Aryl Glucosides with Substituents at the Distal Aryl Ring as Sodium-Dependent Glucose Cotransporter Inhibitors for the Treatment of Diabetes Mellitus.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Design; Glucosides; Glycosuria; Hypoglycemic Agents; Male; Mice; Random Allocation; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transport Proteins; Structure-Activity Relationship | 2015 |
Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Fibromyalgia; Gene Expression; Glucosides; Glycation End Products, Advanced; Hypoglycemic Agents; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor for Advanced Glycation End Products; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Cyanidin-3-O-glucoside enhanced the function of syngeneic mouse islets transplanted under the kidney capsule or into the portal vein.
Topics: Animals; Anthocyanins; Antioxidants; Apoptosis; Biopsy; Blood Glucose; Cell Survival; Diabetes Mellitus, Experimental; Glucosides; Heme Oxygenase-1; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Islets of Langerhans; Islets of Langerhans Transplantation; Isografts; Kidney; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oxidative Stress; Portal Vein; Proto-Oncogene Proteins c-bcl-2; Repressor Proteins; Survivin | 2015 |
Design, Synthesis and in vivo Evaluation of Novel C-Aryl Glucosides as Potent Sodium-Dependent Glucose Cotransporters Inhibitors for the Treatment of Diabetes.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drug Design; Glucosides; Hypoglycemic Agents; Male; Mice; Pancreas; Sodium-Glucose Transport Proteins | 2015 |
Salidroside ameliorates insulin resistance through activation of a mitochondria-associated AMPK/PI3K/Akt/GSK3β pathway.
Topics: Adipose Tissue; AMP-Activated Protein Kinases; Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hepatocytes; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Oxygen Consumption; Pancreas; Phenols; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt | 2015 |
Antidiabetic Effects of Aqueous Infusions of Artemisia herba-alba and Ajuga iva in Alloxan-Induced Diabetic Rats.
Topics: Ajuga; Alloxan; Animals; Apigenin; Artemisia; Blood Glucose; Chlorogenic Acid; Diabetes Mellitus, Experimental; Disease Models, Animal; Glucosides; Glyburide; Hypoglycemic Agents; Medicine, Traditional; Molecular Structure; Plants, Medicinal; Polyphenols; Rats; Rats, Wistar | 2015 |
Endoplasmic reticulum stress in diabetic mouse or glycated LDL-treated endothelial cells: protective effect of Saskatoon berry powder and cyanidin glycans.
Topics: Animals; Anthocyanins; Benzothiazoles; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Endothelium, Vascular; Galactosides; Glucosides; Heart; Humans; Lipoproteins, LDL; Male; Mice, Inbred C57BL; Powders; Protective Agents; Rosaceae; Thiazoles; Transcription Factor CHOP; Unfolded Protein Response; X-Box Binding Protein 1 | 2015 |
Reduction in the amplitude of shortening and Ca(2+) transient by phlorizin and quercetin-3-O-glucoside in ventricular myocytes from streptozotocin-induced diabetic rats.
Topics: Animals; Calcium; Cells, Cultured; Diabetes Mellitus, Experimental; Flavonoids; Glucosides; Heart Ventricles; Myocytes, Cardiac; Phlorhizin; Quercetin; Rats; Sarcoplasmic Reticulum; Streptozocin | 2016 |
Effects of the combination of SGLT2 selective inhibitor ipragliflozin and various antidiabetic drugs in type 2 diabetic mice.
Topics: Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Dose-Response Relationship, Drug; Drug Therapy, Combination; Glucosides; Hypoglycemic Agents; Kidney; Male; Mice, Inbred ICR; Niacinamide; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes; Time Factors | 2016 |
Short-term selective alleviation of glucotoxicity and lipotoxicity ameliorates the suppressed expression of key β-cell factors under diabetic conditions.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Bezafibrate; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Gene Expression; Glucose; Glucosides; Hypoglycemic Agents; Islets of Langerhans; Lipids; Mice | 2015 |
Amelioration of Hyperglycemia with a Sodium-Glucose Cotransporter 2 Inhibitor Prevents Macrophage-Driven Atherosclerosis through Macrophage Foam Cell Formation Suppression in Type 1 and Type 2 Diabetic Mice.
Topics: Animals; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Models, Animal; Foam Cells; Gene Expression; Glucose Tolerance Test; Glucosides; Hyperglycemia; Hypoglycemic Agents; Macrophages, Peritoneal; Male; Mice; Mice, Knockout; Sodium-Glucose Transporter 2 Inhibitors | 2015 |
Beneficial metabolic actions of a stable GIP agonist following pre-treatment with a SGLT2 inhibitor in high fat fed diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Body Composition; Body Weight; Bone Density; Diabetes Mellitus, Experimental; Diet, High-Fat; Energy Metabolism; Fasting; Gastric Inhibitory Polypeptide; Glucosides; Homeostasis; Insulin; Islets of Langerhans; Male; Mice; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
The Effects of Empagliflozin, an SGLT2 Inhibitor, on Pancreatic β-Cell Mass and Glucose Homeostasis in Type 1 Diabetes.
Topics: Animals; Apoptosis; Area Under Curve; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucose; Glucose Tolerance Test; Glucosides; Homeostasis; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Organ Size; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Effect of ipragliflozin, an SGLT2 inhibitor, on progression of diabetic microvascular complications in spontaneously diabetic Torii fatty rats.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; Disease Progression; Glucosides; Hyperglycemia; Hypoglycemic Agents; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2016 |
Polydatin attenuates AGEs-induced upregulation of fibronectin and ICAM-1 in rat glomerular mesangial cells and db/db diabetic mice kidneys by inhibiting the activation of the SphK1-S1P signaling pathway.
Topics: Animals; Cells, Cultured; Diabetes Mellitus, Experimental; Drugs, Chinese Herbal; Female; Fibronectins; Glomerular Mesangium; Glucosides; Glycation End Products, Advanced; Humans; Hypoglycemic Agents; Intercellular Adhesion Molecule-1; Lysophospholipids; Male; Mice; Phosphotransferases (Alcohol Group Acceptor); Rats; Rats, Sprague-Dawley; Signal Transduction; Sphingosine; Stilbenes; Up-Regulation | 2016 |
Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates the development of liver fibrosis in diabetic Otsuka Long-Evans Tokushima fatty rats.
Topics: Animals; Body Weight; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Glucosides; Hepatic Stellate Cells; Hypoglycemic Agents; Insulin Resistance; Liver; Liver Cirrhosis, Experimental; Male; Obesity; Organ Size; Rats, Inbred OLETF; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2016 |
Antidiabetic and antioxidant effects of saponarin from Gypsophila trichotoma on streptozotocin-induced diabetic normotensive and hypertensive rats.
Topics: Animals; Antioxidants; Apigenin; Blood Glucose; Blood Pressure; Caryophyllaceae; Diabetes Mellitus, Experimental; Glucosides; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Glutathione Transferase; Hypertension; Hypoglycemic Agents; Liver; Male; Malondialdehyde; Molecular Structure; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Streptozocin | 2016 |
[Effect and mechanism of polydatin on diabetic myocardial hypertrophy in mice].
Topics: Animals; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Drugs, Chinese Herbal; Glucosides; Humans; Hypertrophy; Insulin; Male; Mice; NF-kappa B; Signal Transduction; Stilbenes | 2015 |
Anti-diabetic effects of luteolin and luteolin-7-O-glucoside on KK-A(y) mice.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, Carbohydrate Loading; Flavones; Glucosides; Hypoglycemic Agents; Insulin; Lipid Metabolism; Liver; Luteolin; Male; Mice; Mice, Transgenic | 2016 |
Once daily administration of the SGLT2 inhibitor, empagliflozin, attenuates markers of renal fibrosis without improving albuminuria in diabetic db/db mice.
Topics: Albuminuria; Animals; Benzhydryl Compounds; Biomarkers; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Models, Animal; Drug Administration Schedule; Glucosides; Hepatitis A Virus Cellular Receptor 1; Hypoglycemic Agents; Lipocalin-2; Male; Mice; Treatment Outcome | 2016 |
Phenylpropenoic Acid Glucoside from Rooibos Protects Pancreatic Beta Cells against Cell Death Induced by Acute Injury.
Topics: Aged; Aged, 80 and over; Animals; Apoptosis; Aspalathus; Blood Glucose; Cell Death; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Experimental; Glucosides; Humans; Insulin-Secreting Cells; Male; Mice, Inbred BALB C; Middle Aged; Phenylpropionates; Plant Extracts; Protective Agents | 2016 |
Evaluation of wound healing properties of bioactive aqueous fraction from Moringa oleifera Lam on experimentally induced diabetic animal model.
Topics: Animals; Anti-Bacterial Agents; Apigenin; Diabetes Mellitus, Experimental; Diabetic Foot; Disease Models, Animal; Dose-Response Relationship, Drug; Escherichia coli; Glucosides; Male; Microbial Sensitivity Tests; Moringa oleifera; Niacinamide; Plant Extracts; Pseudomonas aeruginosa; Rats, Wistar; Staphylococcus aureus; Streptozocin; Structure-Activity Relationship; Water; Wound Healing | 2016 |
Sodium-Glucose Cotransporter 2 Inhibitor and a Low Carbohydrate Diet Affect Gluconeogenesis and Glycogen Content Differently in the Kidney and the Liver of Non-Diabetic Mice.
Topics: Animals; Body Weight; Cyclic AMP Response Element-Binding Protein; Diabetes Mellitus, Experimental; Diet, Carbohydrate-Restricted; Energy Intake; Fatty Acid Synthases; Forkhead Box Protein O1; Gluconeogenesis; Glucose Tolerance Test; Glucosides; Glycogen; Hyperglycemia; Insulin Resistance; Kidney; Lipid Metabolism; Liver; Male; Mice, Inbred C57BL; Obesity; RNA, Messenger; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triglycerides; Up-Regulation | 2016 |
2,3,5,4'-Tetrahydroxystilbene-2-O-β-d-glucoside exerted protective effects on diabetic nephropathy in mice with hyperglycemia induced by streptozotocin.
Topics: Albuminuria; Animals; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Gene Expression Regulation; Glucosides; Kidney; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Stilbenes | 2016 |
Effect of Dapagliflozin Treatment on Fluid and Electrolyte Balance in Diabetic Rats.
Topics: Animals; Aquaporin 2; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Kidney; Male; Membrane Transport Proteins; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Solute Carrier Family 12, Member 1; Urea Transporters; Water-Electrolyte Balance | 2016 |
TGP attenuates endoplasmic reticulum stress and regulates the expression of thioredoxin-interacting protein in the kidneys of diabetic rats.
Topics: Animals; Carrier Proteins; Cell Cycle Proteins; Diabetes Mellitus, Experimental; eIF-2 Kinase; Endoplasmic Reticulum Stress; Eukaryotic Initiation Factor-2; Gene Expression Regulation; Glucosides; HSP70 Heat-Shock Proteins; Kidney; Male; Membrane Proteins; Paeonia; Rats; Transcription Factor CHOP | 2017 |
Anti-diabetic activities of cis- and trans-2,3,5,4'-tetrahydroxystilbene 2-O-β-glucopyranoside from Polygonum multiflorum.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Diet, High-Fat; Enzyme Inhibitors; Fallopia multiflora; Glucosides; Hep G2 Cells; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Phosphoenolpyruvate Carboxykinase (ATP); Stilbenes | 2017 |
The SGLT-2 Inhibitor Dapagliflozin Has a Therapeutic Effect on Atherosclerosis in Diabetic ApoE
Topics: Animals; Aorta; Apolipoproteins E; Atherosclerosis; Benzhydryl Compounds; Blood Glucose; Bone Marrow; Diabetes Complications; Diabetes Mellitus, Experimental; Glucose; Glucosides; Inflammasomes; Interleukin-18; Interleukin-1beta; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NLR Family, Pyrin Domain-Containing 3 Protein; Reactive Oxygen Species; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors | 2016 |
Dapagliflozin-lowered blood glucose reduces respiratory Pseudomonas aeruginosa infection in diabetic mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Bronchoalveolar Lavage Fluid; Diabetes Mellitus, Experimental; Glucosides; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Rats, Wistar; Sodium-Glucose Transport Proteins | 2017 |
Aucubin prevents loss of hippocampal neurons and regulates antioxidative activity in diabetic encephalopathy rats.
Topics: Animals; Antioxidants; Brain Diseases; Cognition Disorders; Diabetes Mellitus, Experimental; Glucosides; Hippocampus; Iridoid Glucosides; Iridoids; Lipid Peroxides; Male; Malondialdehyde; Neurons; Neuroprotective Agents; Nitric Oxide Synthase; Rats; Rats, Wistar | 2009 |
Renoprotective effect of total glucosides of paeony (TGP) and its mechanism in experimental diabetes.
Topics: Animals; Blood Glucose; Body Weight; Cholesterol; Collagen Type I; Creatinine; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Glucosides; Intercellular Adhesion Molecule-1; Interleukin-1; Kidney; Male; Membrane Proteins; Neurotrophin 3; Paeonia; Phytotherapy; Plant Roots; Rats; Rats, Wistar; Transcription Factor RelA; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha | 2009 |
Sergliflozin etabonate, a selective SGLT2 inhibitor, improves glycemic control in streptozotocin-induced diabetic rats and Zucker fatty rats.
Topics: Animals; Area Under Curve; Blood Glucose; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Fasting; Glucose Tolerance Test; Glucosides; Glycated Hemoglobin; Glycosuria; Hypoglycemic Agents; Insulin; Kinetics; Male; Rats; Rats, Zucker; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2009 |
Effect of total glucosides of paeony on the expression of nephrin in the kidneys from diabetic rats.
Topics: Animals; Blotting, Western; Diabetes Mellitus, Experimental; Fluorescent Antibody Technique; Glucosides; Kidney; Male; Membrane Proteins; Paeonia; Rats; Rats, Wistar | 2009 |
[Effect of tripterysium glucosides on diabetic cardiomyopathy in rats].
Topics: Animals; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Experimental; Gene Expression Regulation; Glucosides; Heart; Intercellular Adhesion Molecule-1; Male; Myocardium; NF-kappa B; Rats | 2009 |
Effects of total glucosides of paeony on oxidative stress in the kidney from diabetic rats.
Topics: Albuminuria; Animals; Antioxidants; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Glucosides; Kidney; Male; Malondialdehyde; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Paeonia; Phytotherapy; Rats; Rats, Wistar | 2010 |
Oral supplementation of catalpol ameliorates diabetic encephalopathy in rats.
Topics: Administration, Oral; Animals; Behavior, Animal; Blood Glucose; Body Weight; Catalase; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Glucosides; Glutathione Peroxidase; In Situ Nick-End Labeling; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Male; Malondialdehyde; Maze Learning; Nerve Growth Factor; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Time Factors | 2010 |
The novel anti-hyperglycemic effect of Paeoniae radix via the transcriptional suppression of phosphoenopyruvate carboxykinase (PEPCK).
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Acetophenones; Animals; Benzoates; Bridged-Ring Compounds; Cell Line; Dexamethasone; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Gene Expression; Gluconeogenesis; Glucosides; Humans; Hypoglycemic Agents; Insulin; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Monoterpenes; Paeonia; Palmitic Acid; Phosphoenolpyruvate Carboxykinase (GTP); Phytotherapy; Plant Roots; Rats; Rats, Sprague-Dawley | 2010 |
Amelioration of STZ-induced type 1 diabetic nephropathy by aqueous extract of Enicostemma littorale Blume and swertiamarin in rats.
Topics: Administration, Oral; Animals; Biomarkers; Blood Glucose; Creatinine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drinking; Gentianaceae; Glucosides; Hypertrophy; Hypoglycemic Agents; Iridoid Glucosides; Iridoids; Kidney Glomerulus; Lipids; Male; Plant Extracts; Pyrones; Rats; Rats, Sprague-Dawley; Urea | 2010 |
Antihyperglycemic effect of catalpol in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycogen; Hepatocytes; Hypoglycemic Agents; Insulin; Iridoid Glucosides; Iridoids; Male; Molecular Structure; Muscle, Skeletal; Plant Roots; Plants, Medicinal; Rats; Rats, Wistar; Rehmannia; Taiwan | 2010 |
Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Indoles; Male; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship; Xylose | 2011 |
Synthesis and antihyperglycemic activity of phenolic C-glycosides.
Topics: Animals; Blood Glucose; Cell Line; Chalcones; Diabetes Mellitus, Experimental; Glucosides; Hypoglycemic Agents; Phenols; Pterocarpus; Rats; Structure-Activity Relationship; Ulmus | 2011 |
Hypoglycaemic action of stevioside and а barley and brewer's yeast based preparation in the experimental model on mice.
Topics: Alloxan; Animals; Blood Glucose; Chromium; Diabetes Mellitus, Experimental; Disease Models, Animal; Diterpenes, Kaurane; Epinephrine; Fasting; Female; Glucose; Glucosides; Hordeum; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred Strains; Plant Extracts; Saccharomyces cerevisiae | 2011 |
Antinociceptive effect of paeoniflorin via spinal α₂-adrenoceptor activation in diabetic mice.
Topics: Analgesics; Animals; Animals, Outbred Strains; Benzoates; Bridged-Ring Compounds; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Glucosides; Male; Mice; Monoterpenes; Nociception; Norepinephrine; Receptors, Adrenergic, alpha-2 | 2011 |
[Study on total glucosides of peony preventing non-obese diabetic mice from sialoadenitis].
Topics: Animals; Carrier Proteins; Diabetes Mellitus, Experimental; Female; Glucosides; Mice; Mice, Inbred NOD; Microfilament Proteins; Paeonia; Saliva; Sialadenitis; Sjogren's Syndrome; Submandibular Gland | 2011 |
Acute and chronic effects of SGLT2 blockade on glomerular and tubular function in the early diabetic rat.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Disease Models, Animal; Feedback, Physiological; Glomerular Filtration Rate; Glucosides; Homeostasis; Kidney Glomerulus; Kidney Tubules; Male; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2012 |
Anti-diabetic potential of ursolic acid stearoyl glucoside: a new triterpenic gycosidic ester from Lantana camara.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Hypoglycemic Agents; Lantana; Molecular Structure; Plant Leaves; Rats; Sterols; Triterpenes; Ursolic Acid | 2012 |
Identification of hypoglycaemic compounds from berries of Juniperus oxycedrus subsp. oxycedrus through bioactivity guided isolation technique.
Topics: Animals; Blood Glucose; Coumaric Acids; Diabetes Mellitus, Experimental; Fruit; Glucosides; Hypoglycemic Agents; Juniperus; Male; Medicine, Traditional; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Shikimic Acid; Turkey | 2012 |
Protective effect of salidroside from Rhodiolae Radix on diabetes-induced oxidative stress in mice.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Fasting; Glucosides; Insulin; Kidney; Lipids; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Phenols; Protective Agents; Rhodiola | 2011 |
Pharmacological profile of ipragliflozin (ASP1941), a novel selective SGLT2 inhibitor, in vitro and in vivo.
Topics: Animals; Blood Glucose; Carbohydrate Metabolism; CHO Cells; Cricetinae; Cricetulus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Gastrointestinal Tract; Glucosides; Humans; Hypoglycemic Agents; Insulin; Male; Mice; Mice, Inbred ICR; Phlorhizin; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes | 2012 |
Cyanidin-3-glucoside-rich extract from Chinese bayberry fruit protects pancreatic β cells and ameliorates hyperglycemia in streptozotocin-induced diabetic mice.
Topics: Animals; Anthocyanins; Antioxidants; Cell Line; Cell Survival; China; Diabetes Mellitus, Experimental; Fruit; Gene Expression Regulation; Glucosides; Homeodomain Proteins; Hyperglycemia; Hypoglycemic Agents; Insulin-Like Growth Factor II; Insulin-Secreting Cells; Male; Mice; Mice, Inbred ICR; Myrica; Plant Extracts; Random Allocation; Rats; Reactive Oxygen Species; RNA, Messenger; Trans-Activators | 2012 |
IGF-1 induction by acylated steryl β-glucosides found in a pre-germinated brown rice diet reduces oxidative stress in streptozotocin-induced diabetes.
Topics: Acylation; Animals; Apoptosis; Blood Glucose; Body Weight; Cell Survival; Culture Media; Diabetes Mellitus, Experimental; Diet; Gene Expression Regulation; Germination; Glucose; Glucosephosphate Dehydrogenase; Glucosides; Glycolysis; Insulin; Insulin-Like Growth Factor I; Male; Models, Biological; Oryza; Oxidative Stress; Pentose Phosphate Pathway; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger | 2011 |
Chronic cyanidin-3-glucoside administration improves short-term spatial recognition memory but not passive avoidance learning and memory in streptozotocin-diabetic rats.
Topics: Animals; Anthocyanins; Avoidance Learning; Behavior, Animal; Brain; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Glucosides; Male; Malondialdehyde; Maze Learning; Memory, Short-Term; Mental Recall; Oxidative Stress; Rats; Rats, Wistar; Recognition, Psychology; Spatial Behavior; Streptozocin | 2012 |
Empagliflozin, a novel potent and selective SGLT-2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin-induced diabetic rats, a model of type 1 diabetes mellitus.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Glucosides; Glycated Hemoglobin; Male; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin | 2012 |
Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.
Topics: Animals; Blood Glucose; Body Weight; Canagliflozin; Cells, Cultured; CHO Cells; Cricetinae; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glucosides; Humans; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Rats; Rats, Zucker; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Weight Gain | 2012 |
Tofogliflozin, a potent and highly specific sodium/glucose cotransporter 2 inhibitor, improves glycemic control in diabetic rats and mice.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucose Intolerance; Glucose Tolerance Test; Glucosides; Glycated Hemoglobin; Humans; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred Strains; Rats; Rats, Sprague-Dawley; Rats, Zucker; Sodium-Glucose Transporter 2 Inhibitors | 2012 |
KGA-2727, a novel selective inhibitor of a high-affinity sodium glucose cotransporter (SGLT1), exhibits antidiabetic efficacy in rodent models.
Topics: Animals; Diabetes Mellitus, Experimental; Glucagon-Like Peptide 1; Glucose; Glucosides; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemic Agents; Insulin; Intestinal Absorption; Intestine, Small; Islets of Langerhans; Male; Pyrazoles; Rats; Rats, Wistar; Rats, Zucker; Sodium-Glucose Transporter 1 | 2012 |
Polydatin ameliorates experimental diabetes-induced fibronectin through inhibiting the activation of NF-κB signaling pathway in rat glomerular mesangial cells.
Topics: Active Transport, Cell Nucleus; Animals; Anti-Inflammatory Agents; Cell Nucleus; Cells, Cultured; Cytoprotection; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Fibronectins; Gene Expression; Glucosides; I-kappa B Proteins; Intercellular Adhesion Molecule-1; Kidney; Male; Mesangial Cells; NF-kappa B; NF-KappaB Inhibitor alpha; Organ Size; Protein Binding; Proteolysis; Rats; Rats, Sprague-Dawley; Signal Transduction; Stilbenes; Transforming Growth Factor beta | 2012 |
Total glucosides of paeony regulates JAK2/STAT3 activation and macrophage proliferation in diabetic rat kidneys.
Topics: Albuminuria; Animals; Cell Proliferation; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Glucosides; Janus Kinase 2; Kidney; Macrophages; Male; Paeonia; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Signal Transduction; STAT3 Transcription Factor | 2012 |
Effects of arctiin on streptozotocin-induced diabetic retinopathy in Sprague-Dawley rats.
Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Drugs, Chinese Herbal; Furans; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Male; Random Allocation; Rats; Rats, Sprague-Dawley; Seeds; Streptozocin | 2012 |
Antidiabetic effects of SGLT2-selective inhibitor ipragliflozin in streptozotocin-nicotinamide-induced mildly diabetic mice.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucose; Glucose Tolerance Test; Glucosides; Hypoglycemic Agents; Insulin; Kidney; Male; Mice; Mice, Inbred ICR; Niacinamide; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Streptozocin; Thiophenes | 2012 |
Structure-activity relationship studies of 4-benzyl-1H-pyrazol-3-yl β-d-glucopyranoside derivatives as potent and selective sodium glucose co-transporter 1 (SGLT1) inhibitors with therapeutic activity on postprandial hyperglycemia.
Topics: Animals; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Glucosides; Humans; Hyperglycemia; Hypoglycemic Agents; Molecular Conformation; Rats; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Structure-Activity Relationship | 2012 |
Energy loss via urine and faeces--a combustive analysis in diabetic rats and the impact of antidiabetic treatment on body weight.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucagon-Like Peptide-1 Receptor; Glucosides; Glycated Hemoglobin; Hypoglycemic Agents; Insulin Glargine; Insulin, Long-Acting; Kidney; Male; Peptides; Rats; Rats, Zucker; Receptors, Glucagon; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Weight Gain | 2013 |
Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats.
Topics: Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Furans; Gene Expression Regulation; Glomerular Filtration Barrier; Glucosides; Glucuronidase; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Metabolome; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin | 2013 |
Rhizome of Anemarrhena asphodeloides counteracts diabetic ophthalmopathy progression in streptozotocin-induced diabetic rats.
Topics: Anemarrhena; Animals; Blood Glucose; Cataract; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Glucosides; Glutathione Peroxidase; Glycation End Products, Advanced; Insulin; Lens, Crystalline; Male; Malondialdehyde; Pericytes; Plant Extracts; Rats; Rats, Wistar; Retina; Rhizome; Sorbitol; Streptozocin; Superoxide Dismutase; Xanthones | 2013 |
2, 3, 5, 4'-Tetrahydroxystilbene-2-O-beta-D-glucoside improves gastrointestinal motility disorders in STZ-induced diabetic mice.
Topics: Animals; Caspase 3; Diabetes Mellitus, Experimental; Gastrointestinal Motility; Glucosides; Glutathione Peroxidase; Malondialdehyde; Mice; Nitric Oxide Synthase Type I; Oxidative Stress; Phosphorylation; Stilbenes; Streptozocin | 2012 |
Antidiabetic effect of secoisolariciresinol diglucoside in streptozotocin-induced diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Butylene Glycols; C-Peptide; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Flax; Glucosides; Hypoglycemic Agents; Insulin; Lipid Metabolism; Lipids; Liver; Male; Pancreas; Phytotherapy; Rats; Rats, Wistar | 2013 |
Antioxidant effects of isorhamnetin 3,7-di-O-beta-D-glucopyranoside isolated from mustard leaf (Brassica juncea) in rats with streptozotocin-induced diabetes.
Topics: Animals; Antioxidants; Biphenyl Compounds; Blood Glucose; Brassica; Diabetes Mellitus, Experimental; Flavonols; Free Radical Scavengers; Furaldehyde; Glucosides; Glycated Hemoglobin; Kidney; Male; Mitochondria; Mitochondria, Liver; Picrates; Plant Leaves; Quercetin; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2002 |
Inhibitory effects of isorhamnetin-3-O-beta-D-glucoside from Salicornia herbacea on rat lens aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissues.
Topics: Aldehyde Reductase; Animals; Chenopodiaceae; Diabetes Mellitus, Experimental; Enzyme Inhibitors; Flavonols; Glucosides; Lens, Crystalline; Plant Extracts; Quercetin; Rats; Rats, Sprague-Dawley; Sorbitol; Tissue Distribution | 2005 |
Increase of insulin sensitivity by stevioside in fructose-rich chow-fed rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Dietary Carbohydrates; Diterpenes, Kaurane; Fructose; Glucose Tolerance Test; Glucosides; Insulin Resistance; Male; Phytotherapy; Plant Extracts; Rats; Rats, Wistar; Stevia; Tolbutamide | 2005 |
Indole-glucosides as novel sodium glucose co-transporter 2 (SGLT2) inhibitors. Part 2.
Topics: Animals; Diabetes Mellitus, Experimental; Glucose; Glucosides; Indoles; Molecular Structure; Rats; Rats, Zucker; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2 Inhibitors | 2006 |
Antidiabetic effects of dietary administration of Aloe arborescens Miller components on multiple low-dose streptozotocin-induced diabetes in mice: investigation on hypoglycemic action and systemic absorption dynamics of aloe components.
Topics: Aloe; Animals; Anthracenes; Blood Glucose; Diabetes Mellitus, Experimental; Diet; Emodin; Female; Glucosides; Hypoglycemic Agents; Insulin; Intestinal Absorption; Islets of Langerhans; Mice; Mice, Inbred ICR; Plant Extracts; Plant Leaves; Rats; Rats, Sprague-Dawley; Rats, Wistar; Tissue Distribution | 2006 |
Desoxyrhaponticin (3,5-dihydroxy-4'-methoxystilbene 3-O-beta-D-glucoside) inhibits glucose uptake in the intestine and kidney: In vitro and in vivo studies.
Topics: Animals; Biological Transport; Diabetes Mellitus, Experimental; Glucose; Glucosides; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Intestinal Mucosa; Kidney; Microvilli; Rabbits; Rats; Rats, Wistar; Stilbenes | 2007 |
Cyanidin 3-glucoside ameliorates hyperglycemia and insulin sensitivity due to downregulation of retinol binding protein 4 expression in diabetic mice.
Topics: Adipokines; Adiponectin; Adipose Tissue, White; Animals; Anthocyanins; Blood Glucose; Blotting, Western; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Down-Regulation; Glucose Tolerance Test; Glucose Transporter Type 4; Glucose-6-Phosphatase; Glucosides; Hyperglycemia; Inflammation Mediators; Insulin Resistance; Liver; Male; Mice; Mice, Inbred Strains; Molecular Structure; Receptors, Adiponectin; Retinol-Binding Proteins, Plasma; Reverse Transcriptase Polymerase Chain Reaction | 2007 |
Increase of beta-endorphin secretion by syringin, an active principle of Eleutherococcus senticosus, to produce antihyperglycemic action in type 1-like diabetic rats.
Topics: Adrenal Medulla; Adrenalectomy; Animals; beta-Endorphin; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Eleutherococcus; Glucosides; Hyperglycemia; Hypoglycemic Agents; Injections, Intravenous; Male; Mice; Mice, Knockout; Phenylpropionates; Phytotherapy; Rats; Rats, Wistar; Receptors, Opioid, mu; Streptozocin; Tissue Extracts | 2007 |
Hypoglycemic effect of syringin from Eleutherococcus senticosus in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Eleutherococcus; Glucose; Glucosides; Glycogen; Hepatocytes; Hypoglycemic Agents; Male; Muscle, Skeletal; Phenylpropionates; Plant Roots; Rats; Rats, Wistar; Taiwan | 2008 |
Antioxidant and pancreas-protective effect of aucubin on rats with streptozotocin-induced diabetes.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Glucosides; Glutathione Peroxidase; Immunohistochemistry; Insulin-Secreting Cells; Iridoid Glucosides; Iridoids; Lipid Peroxidation; Male; Malondialdehyde; Pancreas; Protective Agents; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase | 2008 |
Discovery of dapagliflozin: a potent, selective renal sodium-dependent glucose cotransporter 2 (SGLT2) inhibitor for the treatment of type 2 diabetes.
Topics: Administration, Oral; Animals; Benzhydryl Compounds; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Humans; Hypoglycemic Agents; Kidney; Rats; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Stereoisomerism | 2008 |
Neuroprotection of aucubin in primary diabetic encephalopathy.
Topics: Animals; Blotting, Western; Brain Damage, Chronic; Diabetes Complications; Diabetes Mellitus, Experimental; Glucosides; Immunohistochemistry; Iridoid Glucosides; Iridoids; Male; Microscopy, Electron, Transmission; Neuroprotective Agents; Rats; Rats, Wistar | 2008 |
Nonenzymatic glucosylation of serum proteins and hemoglobin: response to changes in blood glucose levels in diabetic rats.
Topics: Animals; Blood Glucose; Blood Proteins; Diabetes Mellitus, Experimental; Glucosides; Glycated Hemoglobin; Glycosides; Hemoglobin A; Insulin; Kinetics; Rats; Serum Albumin | 1980 |
Two new 2-arylbenzofuran derivatives from hypoglycemic activity-bearing fractions of Morus insignis.
Topics: Animals; Benzofurans; Blood Glucose; Child, Preschool; Diabetes Mellitus, Experimental; Glucosides; Humans; Hypoglycemic Agents; Male; Plants, Medicinal; Rats; Rats, Sprague-Dawley; Resorcinols; Stilbenes | 1993 |
Antihyperglycemic activity of phenolics from Pterocarpus marsupium.
Topics: Animals; Benzofurans; Blood Glucose; Body Weight; Cresols; Diabetes Mellitus, Experimental; Female; Glucosides; Hypoglycemic Agents; Male; Metformin; Phenols; Plants, Medicinal; Rats; Stilbenes; Wood | 1997 |
Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora.
Topics: Animals; Benzoates; Blood Glucose; Bridged-Ring Compounds; Diabetes Mellitus, Experimental; Glucosides; Hypoglycemic Agents; Insulin; Medicine, Chinese Traditional; Monoterpenes; Plant Roots; Plants, Medicinal; Rats; Streptozocin | 1997 |
Antidiabetic principles of natural medicines. II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): structures of myrciacitrins I and II and myrciaphenones A and B.
Topics: Acetophenones; Aldehyde Reductase; Animals; Blood Glucose; Brazil; Diabetes Mellitus, Experimental; Flavonoids; Glucosides; Glycoside Hydrolase Inhibitors; Hypoglycemic Agents; Male; Medicine, Traditional; Mice; Microvilli; Plant Extracts; Plants, Medicinal; Rats; Rats, Wistar; Structure-Activity Relationship; Sucrose | 1998 |
T-1095, an inhibitor of renal Na+-glucose cotransporters, may provide a novel approach to treating diabetes.
Topics: Administration, Oral; Animals; Carbonates; Diabetes Mellitus, Experimental; Dogs; Glucose; Glucosides; Humans; Kidney; Male; Mice; Monosaccharide Transport Proteins; Postprandial Period; Rats; Rats, Sprague-Dawley; Sodium; Xenopus | 1999 |
Antidiabetic effect of T-1095, an inhibitor of Na(+)-glucose cotransporter, in neonatally streptozotocin-treated rats.
Topics: Animals; Animals, Newborn; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Glucose Transporter Type 1; Glucose Transporter Type 4; Glucosides; Glycosuria; Hypoglycemic Agents; Insulin; Insulin Secretion; Male; Microvilli; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Rats; Rats, Sprague-Dawley; Sodium | 2000 |
Protective effect of secoisolariciresinol diglucoside against streptozotocin-induced diabetes and its mechanism.
Topics: Animals; Antioxidants; Blood Glucose; Butylene Glycols; Diabetes Mellitus, Experimental; Glucose; Glucosides; Leukocytes; Lipid Peroxidation; Luminescent Measurements; Male; Malondialdehyde; Oxidative Stress; Pancreas; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances | 2000 |
T-1095, a renal Na+-glucose transporter inhibitor, improves hyperglycemia in streptozotocin-induced diabetic rats.
Topics: Albuminuria; Animals; Blood Glucose; Body Weight; Carbonates; Diabetes Mellitus, Experimental; Glucose Transporter Type 2; Glucosides; Glycated Hemoglobin; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Jejunum; Kidney; Male; Monosaccharide Transport Proteins; Organ Size; Rats; Rats, Wistar; Sodium-Glucose Transporter 2; Urine | 2000 |
Correction of hyperglycemia and insulin sensitivity by T-1095, an inhibitor of renal Na+-glucose cotransporters, in streptozotocin-induced diabetic rats.
Topics: Animals; Carbonates; Deoxyglucose; Diabetes Mellitus, Experimental; Glucosides; Hyperglycemia; Hypoglycemic Agents; In Vitro Techniques; Insulin Resistance; Lactic Acid; Male; Monosaccharide Transport Proteins; Muscle, Skeletal; Rats | 2000 |
Antihyperglycemic effect of T-1095 via inhibition of renal Na+-glucose cotransporters in streptozotocin-induced diabetic rats.
Topics: Animals; Blood Glucose; Carbonates; Diabetes Mellitus, Experimental; Glucosides; Glycosuria; Hyperglycemia; Hypoglycemic Agents; Kidney; Male; Microvilli; Monosaccharide Transport Proteins; Rats; Rats, Sprague-Dawley; Rats, Wistar | 2000 |
The effect of foetidin from Momordica foetida on blood glucose level of albino rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Glucosides; Glycosides; Insulin; Phytosterols; Plants, Medicinal; Rats; Sitosterols; Stigmasterol | 1977 |